ID;PMID;Title;Authors;Citation;First Author;Journal/Book;Publication Year;Create Date;PMCID;NIHMS ID;DOI
2;21345815;EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome;"Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, Ramos-Casals M, Dörner T, Bombardieri S, Hachulla E, Brun JG, Kruize AA, Praprotnik S, Tomsic M, Gottenberg JE, Devauchelle V, Devita S, Vollenweider C, Mandl T, Tzioufas A, Carsons S, Saraux A, Sutcliffe N, Vitali C, Bowman SJ; EULAR Sjögren's Task Force.";"Ann Rheum Dis. 2011 Jun;70(6):968-72. doi: 10.1136/ard.2010.143743. Epub 2011 Feb 22.";Seror R;Ann Rheum Dis;2011;25/02/2011;NA;NA;10.1136/ard.2010.143743
3;16297185;The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus;Albrecht J, Taylor L, Berlin JA, Dulay S, Ang G, Fakharzadeh S, Kantor J, Kim E, Militello G, McGinnis K, Richardson S, Treat J, Vittorio C, Van Voorhees A, Werth VP.;"J Invest Dermatol. 2005 Nov;125(5):889-94. doi: 10.1111/j.0022-202X.2005.23889.x.";Albrecht J;J Invest Dermatol;2005;22/11/2005;PMC3928016;NIHMS481525;10.1111/j.0022-202X.2005.23889.x
4;30155940;Defining and validating a Body Skin Discomfort Index (BSDI);Segot-Chicq E, Salah S, Jullien M, Portal N, Deschodt C, Gagnebien D.;"Int J Cosmet Sci. 2018 Oct;40(5):488-493. doi: 10.1111/ics.12490. Epub 2018 Oct 4.";Segot-Chicq E;Int J Cosmet Sci;2018;30/08/2018;NA;NA;10.1111/ics.12490
5;29517552;Validation of SIMPLE Index for Lupus Disease Activity;Gandhi N, Arora S, Sengupta M, Sequeira W, Jolly M, Block JA.;"J Clin Rheumatol. 2018 Sep;24(6):313-318. doi: 10.1097/RHU.0000000000000738.";Gandhi N;J Clin Rheumatol;2018;09/03/2018;NA;NA;10.1097/RHU.0000000000000738
6;28596001;Establishing and Validating an Ichthyosis Severity Index;Marukian NV, Deng Y, Gan G, Ren I, Thermidor W, Craiglow BG, Milstone LM, Choate KA.;"J Invest Dermatol. 2017 Sep;137(9):1834-1841. doi: 10.1016/j.jid.2017.04.037. Epub 2017 Jun 6.";Marukian NV;J Invest Dermatol;2017;10/06/2017;NA;NA;10.1016/j.jid.2017.04.037
7;32703843;Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI);"Piga M, Floris A, Espinosa G, Serpa Pinto L, Kougkas N, Lo Monaco A, Lopalco G, Orlando I, Pirani V, Santos E, Bertsias G, Cantarini L, Cauli A, Cervera R, Correia J, Govoni M, Iannone F, Neri P, Martins Silva A, Vasconcelos C, Muntoni M, Mathieu A; the BODI Project Group.";"RMD Open. 2020 Jul;6(2):e001192. doi: 10.1136/rmdopen-2020-001192.";Piga M;RMD Open;2020;25/07/2020;PMC7425117;NA;10.1136/rmdopen-2020-001192
8;18067478;Development and validation of the Dermatomyositis Skin Severity Index;Carroll CL, Lang W, Snively B, Feldman SR, Callen J, Jorizzo JL.;"Br J Dermatol. 2008 Feb;158(2):345-50. doi: 10.1111/j.1365-2133.2007.08342.x. Epub 2007 Dec 7.";Carroll CL;Br J Dermatol;2008;11/12/2007;NA;NA;10.1111/j.1365-2133.2007.08342.x
9;33320752;Therapeutic Index for Local Infections score validity: a retrospective European analysis;Dissemond J, Strohal R, Mastronicola D, Senneville E, Moisan C, Edward-Jones V, Mahoney K, Junka A, Bartoszewicz M, Verdú-Soriano J.;"J Wound Care. 2020 Dec 2;29(12):726-734. doi: 10.12968/jowc.2020.29.12.726.";Dissemond J;J Wound Care;2020;15/12/2020;NA;NA;10.12968/jowc.2020.29.12.726
10;34288457;Development and validation of a Behçet's Disease Damage Index for adults with BD: An Explicit, Composite and Rated (ECR) tool;"Gheita TA, Hammam N, Fawzy SM, Abd El-Latif E, El-Gazzar II, Samy N, El-Hammady DH, Abdel Noor R, El-Shebini E, El-Najjar AR, Eesa NN, Salem MN, Ibrahim SE, El-Essawi DF, Elsaman AM, Senara S, Fathi HM, Sallam RA, El Shereef RR, Abd Elazeem MI, Fawzy RM, Khalil NM, Shahin D, El-Saadany HM, ElKhalifa M, Nasef SI, Abdalla AM, Noshy N, Said EA, Saad E, Moshrif AH, El-Shanawany AT, Abdel-Fattah YH, Raafat HA, Khalil HM; Egyptian College of Rheumatology-Behçet's Disease Study Group (ECR-BDSG).";"Int J Rheum Dis. 2021 Aug;24(8):1071-1079. doi: 10.1111/1756-185X.14166. Epub 2021 Jul 19.";Gheita TA;Int J Rheum Dis;2021;21/07/2021;NA;NA;10.1111/1756-185X.14166
11;33247832;Development and validation of a new method for potential use of Psoriasis Area and Severity Index in teledermatology;Wu J, Petto H, Dutronc Y, Burkhardt N, Gebauer K, Gooderham M.;"Australas J Dermatol. 2021 Feb;62(1):e114-e117. doi: 10.1111/ajd.13412. Epub 2020 Aug 16.";Wu J;Australas J Dermatol;2021;28/11/2020;PMC7891613;NA;10.1111/ajd.13412
12;22106113;A new classification system for grading the severity of onychomycosis: Onychomycosis Severity Index;Carney C, Tosti A, Daniel R, Scher R, Rich P, DeCoster J, Elewski B.;"Arch Dermatol. 2011 Nov;147(11):1277-82. doi: 10.1001/archdermatol.2011.267.";Carney C;Arch Dermatol;2011;23/11/2011;NA;NA;10.1001/archdermatol.2011.267
13;18311759;The Cutaneous Lupus Erythematosus Disease Activity and Severity Index: expansion for rheumatology and dermatology;Krathen MS, Dunham J, Gaines E, Junkins-Hopkins J, Kim E, Kolasinski SL, Kovarik C, Kwan-Morley J, Okawa J, Propert K, Rogers N, Rose M, Thomas P, Troxel AB, Van Voorhees A, Feldt JV, Weber AL, Werth VP.;"Arthritis Rheum. 2008 Mar 15;59(3):338-44. doi: 10.1002/art.23319.";Krathen MS;Arthritis Rheum;2008;04/03/2008;NA;NA;10.1002/art.23319
14;24173182;Psoriasis: correlation between severity index (PASI) and quality of life index (DLQI) in patients assessed before and after systemic treatment;Silva MF, Fortes MR, Miot LD, Marques SA.;"An Bras Dermatol. 2013 Sep-Oct;88(5):760-3. doi: 10.1590/abd1806-4841.20132052.";Silva MF;An Bras Dermatol;2013;01/11/2013;PMC3798353;NA;10.1590/abd1806-4841.20132052
15;28004387;The reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) among dermatologists, rheumatologists and neurologists;Tiao J, Feng R, Bird S, Choi JK, Dunham J, George M, Gonzalez-Rivera TC, Kaufman JL, Khan N, Luo JJ, Micheletti R, Payne AS, Price R, Quinn C, Rubin AI, Sreih AG, Thomas P, Okawa J, Werth VP.;"Br J Dermatol. 2017 Feb;176(2):423-430. doi: 10.1111/bjd.15140. Epub 2016 Dec 22.";Tiao J;Br J Dermatol;2017;23/12/2016;PMC5843482;NIHMS825325;10.1111/bjd.15140
16;20398960;Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method;Pandya AG, Hynan LS, Bhore R, Riley FC, Guevara IL, Grimes P, Nordlund JJ, Rendon M, Taylor S, Gottschalk RW, Agim NG, Ortonne JP.;"J Am Acad Dermatol. 2011 Jan;64(1):78-83, 83.e1-2. doi: 10.1016/j.jaad.2009.10.051. Epub 2010 Apr 15.";Pandya AG;J Am Acad Dermatol;2011;20/04/2010;NA;NA;10.1016/j.jaad.2009.10.051
17;23107310;Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures;Jolly M, Kazmi N, Mikolaitis RA, Sequeira W, Block JA.;"J Am Acad Dermatol. 2013 Apr;68(4):618-623. doi: 10.1016/j.jaad.2012.08.035. Epub 2012 Oct 26.";Jolly M;J Am Acad Dermatol;2013;31/10/2012;NA;NA;10.1016/j.jaad.2012.08.035
18;23807685;The Simplified Psoriasis Index (SPI): a practical tool for assessing psoriasis;Chularojanamontri L, Griffiths CE, Chalmers RJ.;"J Invest Dermatol. 2013 Aug;133(8):1956-62. doi: 10.1038/jid.2013.138. Epub 2013 Mar 20.";Chularojanamontri L;J Invest Dermatol;2013;29/06/2013;NA;NA;10.1038/jid.2013.138
19;12453138;Debridement performance index and its correlation with complete closure of diabetic foot ulcers;Saap LJ, Falanga V.;"Wound Repair Regen. 2002 Nov-Dec;10(6):354-9. doi: 10.1046/j.1524-475x.2002.10603.x.";Saap LJ;Wound Repair Regen;2002;28/11/2002;NA;NA;10.1046/j.1524-475x.2002.10603.x
20;24355263;Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI);Loh CC, Kim J, Su JC, Daniel BS, Venugopal SS, Rhodes LM, Intong LR, Law MG, Murrell DF.;"J Am Acad Dermatol. 2014 Jan;70(1):89-97.e1-13. doi: 10.1016/j.jaad.2013.09.041.";Loh CC;J Am Acad Dermatol;2014;21/12/2013;NA;NA;10.1016/j.jaad.2013.09.041
21;25346300;Grading criteria for disease severity by pemphigus disease area index;Shimizu T, Takebayashi T, Sato Y, Niizeki H, Aoyama Y, Kitajima Y, Iwatsuki K, Hashimoto T, Yamagami J, Werth VP, Amagai M, Tanikawa A.;"J Dermatol. 2014 Nov;41(11):969-73. doi: 10.1111/1346-8138.12649.";Shimizu T;J Dermatol;2014;28/10/2014;NA;NA;10.1111/1346-8138.12649
22;28168736;Assessment of a 3-Dimensional Computerised psoriasis area and severity index (PASI) Tool for calculating and documenting PASI scores;Goon PKC, Farooqui UA, Koopmans I, Skellett AM, Levell NJ.;"J Eur Acad Dermatol Venereol. 2017 Aug;31(8):e352-e353. doi: 10.1111/jdv.14154. Epub 2017 Feb 28.";Goon PKC;J Eur Acad Dermatol Venereol;2017;08/02/2017;NA;NA;10.1111/jdv.14154
23;28401585;A proposed scoring system for assessing the severity of actinic keratosis on the head: actinic keratosis area and severity index;"Dirschka T, Pellacani G, Micali G, Malvehy J, Stratigos AJ, Casari A, Schmitz L, Gupta G; Athens AK Study Group.";"J Eur Acad Dermatol Venereol. 2017 Aug;31(8):1295-1302. doi: 10.1111/jdv.14267. Epub 2017 May 3.";Dirschka T;J Eur Acad Dermatol Venereol;2017;13/04/2017;NA;NA;10.1111/jdv.14267
24;12622629;Performance of the self-administered psoriasis area and severity index in evaluating clinical and sociodemographic subgroups of patients with psoriasis;"Sampogna F, Sera F, Mazzotti E, Pasquini P, Picardi A, Abeni D; IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) Study Group.";"Arch Dermatol. 2003 Mar;139(3):353-8; discussion 357. doi: 10.1001/archderm.139.3.353.";Sampogna F;Arch Dermatol;2003;08/03/2003;NA;NA;10.1001/archderm.139.3.353
25;24772225;Pemphigus: use of the Japanese severity index in 56 Moroccan patients;Benchikhi H, Nani S, Baybay H, Amal S, Mernissi FZ.;"Pan Afr Med J. 2013 Nov 14;16:96. doi: 10.11604/pamj.2013.16.96.2184. eCollection 2013.";Benchikhi H;Pan Afr Med J;2013;29/04/2014;PMC3996439;NA;10.11604/pamj.2013.16.96.2184
26;29572818;Actinic Keratosis Area Severity Index (AKASI): reproducibility study and comparison with total lesion count;Pellacani G, Gupta G, Micali G, Malvehy J, Stratigos AJ, Casari A, Chester J, Kaleci S, Dirschka T.;"Br J Dermatol. 2018 Sep;179(3):763-764. doi: 10.1111/bjd.16559. Epub 2018 Jun 20.";Pellacani G;Br J Dermatol;2018;25/03/2018;NA;NA;10.1111/bjd.16559
27;25641313;Pilot study of an automated method to determine Melasma Area and Severity Index;Tay EY, Gan EY, Tan VWD, Lin Z, Liang Y, Lin F, Wee S, Thng TG.;"Br J Dermatol. 2015 Jun;172(6):1535-1540. doi: 10.1111/bjd.13699. Epub 2015 May 12.";Tay EY;Br J Dermatol;2015;03/02/2015;NA;NA;10.1111/bjd.13699
28;16842554;Osnabrueck hand eczema severity index--a study of the interobserver reliability of a scoring system assessing skin diseases of the hands;Skudlik C, Dulon M, Pohrt U, Appl KC, John SM, Nienhaus A.;"Contact Dermatitis. 2006 Jul;55(1):42-7. doi: 10.1111/j.0105-1873.2006.00871.x.";Skudlik C;Contact Dermatitis;2006;18/07/2006;NA;NA;10.1111/j.0105-1873.2006.00871.x
29;16309471;Using the Dermatology Index of Disease Severity (DIDS) to assess the responsiveness of dermatitis;Hahn HB, Chuang TY.;"Clin Exp Dermatol. 2006 Jan;31(1):19-22. doi: 10.1111/j.1365-2230.2005.02001.x.";Hahn HB;Clin Exp Dermatol;2006;29/11/2005;NA;NA;10.1111/j.1365-2230.2005.02001.x
30;19016701;Validity and responsiveness of the Osnabrück Hand Eczema Severity Index (OHSI): a methodological study;Dulon M, Skudlik C, Nübling M, John SM, Nienhaus A.;"Br J Dermatol. 2009 Jan;160(1):137-42. doi: 10.1111/j.1365-2133.2008.08870.x. Epub 2008 Oct 25.";Dulon M;Br J Dermatol;2009;20/11/2008;NA;NA;10.1111/j.1365-2133.2008.08870.x
31;25011586;Assessment of bullous pemphigoid disease area index during treatment: a prospective study of 30 patients;Lévy-Sitbon C, Barbe C, Plee J, Goeldel AL, Antonicelli F, Reguiaï Z, Jolly D, Grange F, Bernard P.;"Dermatology. 2014;229(2):116-22. doi: 10.1159/000362717. Epub 2014 Jul 5.";Lévy-Sitbon C;Dermatology;2014;12/07/2014;NA;NA;10.1159/000362717
32;17263798;Comparative efficacy of topical antipsoriatic treatments, systemic treatment and biologics: is severity assessment beyond Psoriasis Area and Severity Index a necessity?;van de Kerkhof PC, Mrowietz U, Segaert S, Kragballe K.;"Br J Dermatol. 2007 Apr;156(4):771-2. doi: 10.1111/j.1365-2133.2006.07747.x. Epub 2007 Jan 30.";van de Kerkhof PC;Br J Dermatol;2007;01/02/2007;NA;NA;10.1111/j.1365-2133.2006.07747.x
33;18211416;The comparison of Nail Psoriasis Severity Index with a less time-consuming qualitative system;Kaçar N, Ergin S, Erdoğan BS.;"J Eur Acad Dermatol Venereol. 2008 Feb;22(2):219-22. doi: 10.1111/j.1468-3083.2007.02389.x.";Kaçar N;J Eur Acad Dermatol Venereol;2008;24/01/2008;NA;NA;10.1111/j.1468-3083.2007.02389.x
34;19558005;The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria;Jariwala SP, Moday H, de Asis ML, Fodeman J, Hudes G, de Vos G, Rosenstreich D.;"Ann Allergy Asthma Immunol. 2009 Jun;102(6):475-82. doi: 10.1016/S1081-1206(10)60120-2.";Jariwala SP;Ann Allergy Asthma Immunol;2009;30/06/2009;NA;NA;10.1016/S1081-1206(10)60120-2
35;24176524;Reliability assessment and validation of the postacne hyperpigmentation index (PAHPI), a new instrument to measure postinflammatory hyperpigmentation from acne vulgaris;Savory SA, Agim NG, Mao R, Peter S, Wang C, Maldonado G, Bearden Dietert J, Lieu TJ, Wang C, Pretzlaff K, Das S, Vandergriff T, Lopez IE, Litzner BR, Hynan LS, Arellano-Mendoza MI, Bergstresser PR, Pandya AG.;"J Am Acad Dermatol. 2014 Jan;70(1):108-14. doi: 10.1016/j.jaad.2013.09.017. Epub 2013 Oct 28.";Savory SA;J Am Acad Dermatol;2014;02/11/2013;NA;NA;10.1016/j.jaad.2013.09.017
36;29180097;Lack of correlation of the patient-derived Vitiligo Disease Activity Index with the clinician-derived Vitiligo Area Scoring Index;Coias J, Hynan LS, Pandya AG.;"J Am Acad Dermatol. 2018 May;78(5):1015-1016. doi: 10.1016/j.jaad.2017.11.034. Epub 2017 Nov 24.";Coias J;J Am Acad Dermatol;2018;29/11/2017;NA;NA;10.1016/j.jaad.2017.11.034
37;28365082;Vascular Psoriasis Area Severity Index: A dermoscopic standard technique for assessing severity psoriasis and therapeutic management;Carlesimo M, Garelli V, Fortuna MC, De Vita G, Sorriso-Valvo L, Buccolini F, Melini A, Di Nunno D, Pranteda G, Rossi A.;"J Dermatol Sci. 2017 Jun;86(3):249-251. doi: 10.1016/j.jdermsci.2017.03.010. Epub 2017 Mar 21.";Carlesimo M;J Dermatol Sci;2017;03/04/2017;NA;NA;10.1016/j.jdermsci.2017.03.010
38;17216680;The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis;Cassell SE, Bieber JD, Rich P, Tutuncu ZN, Lee SJ, Kalunian KC, Wu CW, Kavanaugh A.;"J Rheumatol. 2007 Jan;34(1):123-9.";Cassell SE;J Rheumatol;2007;12/01/2007;NA;NA;NA
39;8752834;Disease severity measures in a population of psoriasis patients: the symptoms of psoriasis correlate with self-administered psoriasis area severity index scores;Fleischer AB Jr, Feldman SR, Rapp SR, Reboussin DM, Exum ML, Clark AR, Rajashekhar V.;"J Invest Dermatol. 1996 Jul;107(1):26-9. doi: 10.1111/1523-1747.ep12297659.";Fleischer AB Jr;J Invest Dermatol;1996;01/07/1996;NA;NA;10.1111/1523-1747.ep12297659
40;15210457;Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index;Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H.;"Arch Dermatol. 2004 Jun;140(6):677-83. doi: 10.1001/archderm.140.6.677.";Hamzavi I;Arch Dermatol;2004;24/06/2004;NA;NA;10.1001/archderm.140.6.677
41;15727643;The hand eczema severity index (HECSI): a scoring system for clinical assessment of hand eczema. A study of inter- and intraobserver reliability;Held E, Skoet R, Johansen JD, Agner T.;"Br J Dermatol. 2005 Feb;152(2):302-7. doi: 10.1111/j.1365-2133.2004.06305.x.";Held E;Br J Dermatol;2005;25/02/2005;NA;NA;10.1111/j.1365-2133.2004.06305.x
42;10809855;A multicentre study of percentage change in venous leg ulcer area as a prognostic index of healing at 24 weeks;Kantor J, Margolis DJ.;"Br J Dermatol. 2000 May;142(5):960-4. doi: 10.1046/j.1365-2133.2000.03478.x.";Kantor J;Br J Dermatol;2000;16/05/2000;NA;NA;10.1046/j.1365-2133.2000.03478.x
43;15727666;The Self-Administered Psoriasis Area and Severity Index provides an objective measure of psoriasis severity;Feldman SR, Clark AR, Venkat AP, Fleischer AB Jr, Anderson RT, Rajagopalan R.;"Br J Dermatol. 2005 Feb;152(2):382-3. doi: 10.1111/j.1365-2133.2005.06351.x.";Feldman SR;Br J Dermatol;2005;25/02/2005;NA;NA;10.1111/j.1365-2133.2005.06351.x
44;32959390;What are the best endpoints for Eczema Area and Severity Index and Scoring Atopic Dermatitis in clinical practice? A prospective observational study;Silverberg JI, Lei D, Yousaf M, Janmohamed SR, Vakharia PP, Chopra R, Chavda R, Gabriel S, Patel KR, Singam V, Kantor R, Hsu DY.;"Br J Dermatol. 2021 May;184(5):888-895. doi: 10.1111/bjd.19457. Epub 2020 Sep 21.";Silverberg JI;Br J Dermatol;2021;22/09/2020;PMC7862410;NIHMS1629550;10.1111/bjd.19457
45;12452870;Use of the Self-Administered Eczema Area and Severity Index by parent caregivers: results of a validation study;Housman TS, Patel MJ, Camacho F, Feldman SR, Fleischer AB Jr, Balkrishnan R.;"Br J Dermatol. 2002 Dec;147(6):1192-8. doi: 10.1046/j.1365-2133.2002.05031.x.";Housman TS;Br J Dermatol;2002;28/11/2002;NA;NA;10.1046/j.1365-2133.2002.05031.x
46;27976465;Determination of the Nail Psoriasis Severity Index improvement rate standards for nail psoriasis treatment in a phase IV clinical trial of ustekinumab: the MARCOPOLO study;"Youn SW, Kim BR, Cho S, Seo SJ, Lee ES, Roh JY, Choi GS, Lee MG; MARCOPOLO investigators.";"J Eur Acad Dermatol Venereol. 2017 Jun;31(6):e298-e299. doi: 10.1111/jdv.14083. Epub 2017 Jan 3.";Youn SW;J Eur Acad Dermatol Venereol;2017;16/12/2016;NA;NA;10.1111/jdv.14083
47;25278165;Vitiligo Area Scoring Index and Vitiligo European Task Force assessment: reliable and responsive instruments to measure the degree of depigmentation in vitiligo;Komen L, da Graça V, Wolkerstorfer A, de Rie MA, Terwee CB, van der Veen JP.;"Br J Dermatol. 2015 Feb;172(2):437-43. doi: 10.1111/bjd.13432. Epub 2015 Jan 8.";Komen L;Br J Dermatol;2015;04/10/2014;NA;NA;10.1111/bjd.13432
48;27580431;The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa;Jain SV, Harris AG, Su JC, Orchard D, Warren LJ, McManus H, Murrell DF.;"J Eur Acad Dermatol Venereol. 2017 Apr;31(4):692-698. doi: 10.1111/jdv.13953. Epub 2016 Oct 3.";Jain SV;J Eur Acad Dermatol Venereol;2017;01/09/2016;PMC5412907;NA;10.1111/jdv.13953
49;26669549;The Smile Esthetic Index (SEI): A method to measure the esthetics of the smile. An intra-rater and inter-rater agreement study;Rotundo R, Nieri M, Bonaccini D, Mori M, Lamberti E, Massironi D, Giachetti L, Franchi L, Venezia P, Cavalcanti R, Bondi E, Farneti M, Pinchi V, Buti J.;"Eur J Oral Implantol. 2015 Winter;8(4):397-403.";Rotundo R;Eur J Oral Implantol;2015;17/12/2015;NA;NA;NA
50;24429657;Pemphigus disease activity measurements: pemphigus disease area index, autoimmune bullous skin disorder intensity score, and pemphigus vulgaris activity score;Rahbar Z, Daneshpazhooh M, Mirshams-Shahshahani M, Esmaili N, Heidari K, Aghazadeh N, Hejazi P, Ghajarzadeh M, Chams-Davatchi C.;"JAMA Dermatol. 2014 Mar;150(3):266-72. doi: 10.1001/jamadermatol.2013.8175.";Rahbar Z;JAMA Dermatol;2014;17/01/2014;NA;NA;10.1001/jamadermatol.2013.8175
51;12848110;The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison;Gottlieb AB, Chaudhari U, Baker DG, Perate M, Dooley LT.;"J Drugs Dermatol. 2003 Jun;2(3):260-6.";Gottlieb AB;J Drugs Dermatol;2003;10/07/2003;NA;NA;NA
52;18283174;The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus;Bonilla-Martinez ZL, Albrecht J, Troxel AB, Taylor L, Okawa J, Dulay S, Werth VP.;"Arch Dermatol. 2008 Feb;144(2):173-80. doi: 10.1001/archderm.144.2.173.";Bonilla-Martinez ZL;Arch Dermatol;2008;20/02/2008;PMC2829653;NIHMS82310;10.1001/archderm.144.2.173
53;9298136;The applicability of clinical scoring systems: SCORAD and PASI in psoriasis and atopic dermatitis;Jemec GB, Wulf HC.;"Acta Derm Venereol. 1997 Sep;77(5):392-3. doi: 10.2340/0001555577392393.";Jemec GB;Acta Derm Venereol;1997;23/09/1997;NA;NA;10.2340/0001555577392393
54;15389191;Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment;Langley RG, Ellis CN.;"J Am Acad Dermatol. 2004 Oct;51(4):563-9. doi: 10.1016/j.jaad.2004.04.012.";Langley RG;J Am Acad Dermatol;2004;25/09/2004;NA;NA;10.1016/j.jaad.2004.04.012
55;29068583;The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment;Bożek A, Reich A.;"Adv Clin Exp Med. 2017 Aug;26(5):851-856. doi: 10.17219/acem/69804.";Bożek A;Adv Clin Exp Med;2017;26/10/2017;NA;NA;10.17219/acem/69804
56;34741783;Absolute Psoriasis Area and Severity Index as a valuable marker to determine initial treatment response in psoriasis patients treated with guselkumab in routine clinical care;Seidl U, Pinter A, Wilsmann-Theis D, Poortinga S, Morrison K, Mrowietz U, Gerdes S.;"Dermatol Ther. 2022 Jan;35(1):e15193. doi: 10.1111/dth.15193. Epub 2021 Nov 25.";Seidl U;Dermatol Ther;2022;06/11/2021;NA;NA;10.1111/dth.15193
57;32199977;Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study;Silverberg JI, Lei D, Yousaf M, Janmohamed SR, Vakharia PP, Chopra R, Chavda R, Gabriel S, Patel KR, Singam V, Kantor R, Hsu DY.;"Ann Allergy Asthma Immunol. 2020 Jul;125(1):78-83. doi: 10.1016/j.anai.2020.03.006. Epub 2020 Mar 18.";Silverberg JI;Ann Allergy Asthma Immunol;2020;23/03/2020;NA;NA;10.1016/j.anai.2020.03.006
58;28342016;Severity of Psoriasis Differs Between Men and Women: A Study of the Clinical Outcome Measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register Patients;Hägg D, Sundström A, Eriksson M, Schmitt-Egenolf M.;"Am J Clin Dermatol. 2017 Aug;18(4):583-590. doi: 10.1007/s40257-017-0274-0.";Hägg D;Am J Clin Dermatol;2017;26/03/2017;PMC5506504;NA;10.1007/s40257-017-0274-0
59;18092843;Comparison of skin hydration evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD index, Nottingham Eczema Severity Score, and quality of life in patients with atopic dermatitis;Hon KL, Wong KY, Leung TF, Chow CM, Ng PC.;"Am J Clin Dermatol. 2008;9(1):45-50. doi: 10.2165/00128071-200809010-00005.";Hon KL;Am J Clin Dermatol;2008;21/12/2007;NA;NA;10.2165/00128071-200809010-00005
60;30033560;Evaluation of the reliability and validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in paediatric cutaneous lupus among paediatric dermatologists and rheumatologists;Kushner CJ, Tarazi M, Gaffney RG, Feng R, Ardalan K, Brandling-Bennett HA, Castelo-Soccio L, Chang JC, Chiu YE, Gmuca S, Hunt RD, Kahn PJ, Knight AM, Mehta J, Pearson DR, Treat JR, Wan J, Yeguez AC, Concha JSS, Patel B, Okawa J, Arkin LM, Werth VP.;"Br J Dermatol. 2019 Jan;180(1):165-171. doi: 10.1111/bjd.17012. Epub 2018 Oct 5.";Kushner CJ;Br J Dermatol;2019;24/07/2018;NA;NA;10.1111/bjd.17012
61;26827762;Development and Validation of the Vitiligo Extent Score (VES): an International Collaborative Initiative;van Geel N, Lommerts J, Bekkenk M, Wolkerstorfer A, Prinsen CAC, Eleftheriadou V, Taïeb A, Picardo M, Ezzedine K, Speeckaert R.;"J Invest Dermatol. 2016 May;136(5):978-984. doi: 10.1016/j.jid.2015.12.040. Epub 2016 Jan 28.";van Geel N;J Invest Dermatol;2016;02/02/2016;NA;NA;10.1016/j.jid.2015.12.040
62;9833051;Comparison of actual psoriasis surface area and the psoriasis area and severity index by the human eye and machine vision methods in following the treatment of psoriasis;Savolainen L, Kontinen J, Alatalo E, Röning J, Oikarinen A.;"Acta Derm Venereol. 1998 Nov;78(6):466-7. doi: 10.1080/000155598442818.";Savolainen L;Acta Derm Venereol;1998;02/12/1998;NA;NA;10.1080/000155598442818
63;26800395;Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus;"Boulard C, Duvert Lehembre S, Picard-Dahan C, Kern JS, Zambruno G, Feliciani C, Marinovic B, Vabres P, Borradori L, Prost-Squarcioni C, Labeille B, Richard MA, Ingen-Housz-Oro S, Houivet E, Werth VP, Murrell DF, Hertl M, Benichou J, Joly P; International Pemphigus Study Group.";"Br J Dermatol. 2016 Jul;175(1):142-9. doi: 10.1111/bjd.14405. Epub 2016 Apr 3.";Boulard C;Br J Dermatol;2016;23/01/2016;NA;NA;10.1111/bjd.14405
64;14746622;Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme;Barbier N, Paul C, Luger T, Allen R, De Prost Y, Papp K, Eichenfield LF, Cherill R, Hanifin J.;"Br J Dermatol. 2004 Jan;150(1):96-102. doi: 10.1111/j.1365-2133.2004.05696.x.";Barbier N;Br J Dermatol;2004;30/01/2004;NA;NA;10.1111/j.1365-2133.2004.05696.x
65;11168660;Clinical evaluation of a more rapid and sensitive Psoriasis Assessment Severity Score (PASS), and its comparison with the classic method of Psoriasis Area and Severity Index (PASI), before and after climatotherapy at the Dead-Sea;Harari M, Shani J, Hristakieva E, Stanimirovic A, Seidl W, Burdo A.;"Int J Dermatol. 2000 Dec;39(12):913-8. doi: 10.1046/j.1365-4362.2000.00017.x.";Harari M;Int J Dermatol;2000;13/02/2001;NA;NA;10.1046/j.1365-4362.2000.00017.x
66;20008472;Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study;Arkachaisri T, Vilaiyuk S, Torok KS, Medsger TA Jr.;"Rheumatology (Oxford). 2010 Feb;49(2):373-81. doi: 10.1093/rheumatology/kep361. Epub 2009 Dec 14.";Arkachaisri T;Rheumatology (Oxford);2010;17/12/2009;PMC3498950;NA;10.1093/rheumatology/kep361
67;22211581;Dramatic impact of a Psoriasis Area and Severity Index 90 response on the quality of life in patients with psoriasis: an analysis of Japanese clinical trials of infliximab;"Torii H, Sato N, Yoshinari T, Nakagawa H; Japanese Infliximab Study Investigators.";"J Dermatol. 2012 Mar;39(3):253-9. doi: 10.1111/j.1346-8138.2011.01459.x. Epub 2011 Dec 29.";Torii H;J Dermatol;2012;04/01/2012;NA;NA;10.1111/j.1346-8138.2011.01459.x
68;16965419;A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment;Berth-Jones J, Grotzinger K, Rainville C, Pham B, Huang J, Daly S, Herdman M, Firth P, Hotchkiss K.;"Br J Dermatol. 2006 Oct;155(4):707-13. doi: 10.1111/j.1365-2133.2006.07389.x.";Berth-Jones J;Br J Dermatol;2006;13/09/2006;NA;NA;10.1111/j.1365-2133.2006.07389.x
69;25917315;Comparison of three methods for measuring psoriasis severity in clinical studies (Part 1 of 2): change during therapy in Psoriasis Area and Severity Index, Static Physician's Global Assessment and Lattice System Physician's Global Assessment;Chow C, Simpson MJ, Luger TA, Chubb H, Ellis CN.;"J Eur Acad Dermatol Venereol. 2015 Jul;29(7):1406-14. doi: 10.1111/jdv.13132. Epub 2015 Apr 27.";Chow C;J Eur Acad Dermatol Venereol;2015;29/04/2015;NA;NA;10.1111/jdv.13132
70;25917214;Comparison of three methods for measuring psoriasis severity in clinical studies (Part 2 of 2): use of quality of life to assess construct validity of the Lattice System Physician's Global Assessment, Psoriasis Area and Severity Index and Static Physician's Global Assessment;Simpson MJ, Chow C, Morgenstern H, Luger TA, Ellis CN.;"J Eur Acad Dermatol Venereol. 2015 Jul;29(7):1415-20. doi: 10.1111/jdv.12861. Epub 2015 Apr 27.";Simpson MJ;J Eur Acad Dermatol Venereol;2015;29/04/2015;NA;NA;10.1111/jdv.12861
71;25598172;Evaluation of internal consistency of the epidermolysis bullosa oropharyngeal severity score (EBOS);Fortuna G, Aria M, Cepeda-Valdes R, Salas-Alanís JC.;"Acta Odontol Scand. 2015 Feb;73(2):156-60. doi: 10.3109/00016357.2014.931460. Epub 2015 Jan 19.";Fortuna G;Acta Odontol Scand;2015;20/01/2015;NA;NA;10.3109/00016357.2014.931460
72;27749240;Digital ulcers score: a scoring system to assess digital ulcers in patients suffering from systemic sclerosis;Ahrens HC, Siegert E, Tomsitz D, Mattat K, March C, Worm M, Riemekasten G.;"Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):142-147. Epub 2016 Oct 13.";Ahrens HC;Clin Exp Rheumatol;2016;18/10/2016;NA;NA;NA
73;24698704;Scoring nail psoriasis;Klaassen KM, van de Kerkhof PC, Bastiaens MT, Plusjé LG, Baran RL, Pasch MC.;"J Am Acad Dermatol. 2014 Jun;70(6):1061-6. doi: 10.1016/j.jaad.2014.02.010. Epub 2014 Mar 31.";Klaassen KM;J Am Acad Dermatol;2014;05/04/2014;NA;NA;10.1016/j.jaad.2014.02.010
74;21410676;Scoring of hand eczema: good agreement between patients and dermatological staff;Carlsson A, Gånemo A, Anderson CD, Meding B, Stenberg B, Svensson A.;"Br J Dermatol. 2011 Jul;165(1):123-8. doi: 10.1111/j.1365-2133.2011.10312.x. Epub 2011 May 30.";Carlsson A;Br J Dermatol;2011;18/03/2011;NA;NA;10.1111/j.1365-2133.2011.10312.x
75;30442833;Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis;Bruni C, Ngcozana T, Braschi F, Pucci T, Piemonte G, Benelli L, Poli M, Suliman YA, Guiducci S, Bellando-Randone S, Balduzzi S, Grotts J, Denton CP, Rasero L, Montecucco C, Furst DE, Matucci-Cerinic M.;"J Rheumatol. 2019 Jun;46(6):603-608. doi: 10.3899/jrheum.171486. Epub 2018 Nov 15.";Bruni C;J Rheumatol;2019;17/11/2018;NA;NA;10.3899/jrheum.171486
76;29388188;The PARACELSUS score: a novel diagnostic tool for pyoderma gangrenosum;Jockenhöfer F, Wollina U, Salva KA, Benson S, Dissemond J.;"Br J Dermatol. 2019 Mar;180(3):615-620. doi: 10.1111/bjd.16401. Epub 2018 May 6.";Jockenhöfer F;Br J Dermatol;2019;02/02/2018;NA;NA;10.1111/bjd.16401
77;11338403;Comparison of three techniques for evaluating skin erythemal response for determination of sun protection factors of sunscreens: high resolution laser Doppler imaging, colorimetry and visual scoring;Wilhelm KP, Kaspar K, Funkel O.;"Photodermatol Photoimmunol Photomed. 2001 Apr;17(2):60-5. doi: 10.1034/j.1600-0781.2001.017002060.x.";Wilhelm KP;Photodermatol Photoimmunol Photomed;2001;08/05/2001;NA;NA;10.1034/j.1600-0781.2001.017002060.x
78;2390128;Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis;Clements PJ, Lachenbruch PA, Ng SC, Simmons M, Sterz M, Furst DE.;"Arthritis Rheum. 1990 Aug;33(8):1256-63. doi: 10.1002/art.1780330828.";Clements PJ;Arthritis Rheum;1990;01/08/1990;NA;NA;10.1002/art.1780330828
79;28947289;Development and validation of the Frontal Fibrosing Alopecia Severity Score;Saceda-Corralo D, Moreno-Arrones ÓM, Fonda-Pascual P, Pindado-Ortega C, Buendía-Castaño D, Alegre-Sánchez A, Segurado-Miravalles G, Rodrigues-Barata AR, Jaén-Olasolo P, Vaño-Galván S.;"J Am Acad Dermatol. 2018 Mar;78(3):522-529. doi: 10.1016/j.jaad.2017.09.034. Epub 2017 Sep 22.";Saceda-Corralo D;J Am Acad Dermatol;2018;27/09/2017;NA;NA;10.1016/j.jaad.2017.09.034
80;26611655;Usefulness of Rajka & Langeland Eczema Severity Score in Clinical Practice;Gånemo A, Svensson Å, Svedman C, Grönberg BM, Johansson AC, Wahlgren CF.;"Acta Derm Venereol. 2016 May;96(4):521-4. doi: 10.2340/00015555-2302.";Gånemo A;Acta Derm Venereol;2016;28/11/2015;NA;NA;10.2340/00015555-2302
81;22773386;Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium;Jacobsohn DA, Kurland BF, Pidala J, Inamoto Y, Chai X, Palmer JM, Arai S, Arora M, Jagasia M, Cutler C, Weisdorf D, Martin PJ, Pavletic SZ, Vogelsang G, Lee SJ, Flowers ME.;"Blood. 2012 Sep 27;120(13):2545-52; quiz 2774. doi: 10.1182/blood-2012-04-424135. Epub 2012 Jul 6.";Jacobsohn DA;Blood;2012;10/07/2012;PMC3460679;NA;10.1182/blood-2012-04-424135
82;17672874;Assessment of atopic eczema: clinical scoring and noninvasive measurements;Holm EA, Wulf HC, Thomassen L, Jemec GB.;"Br J Dermatol. 2007 Oct;157(4):674-80. doi: 10.1111/j.1365-2133.2007.08101.x. Epub 2007 Aug 2.";Holm EA;Br J Dermatol;2007;04/08/2007;NA;NA;10.1111/j.1365-2133.2007.08101.x
83;28809373;Scoring systems for Oral Lichen Planus used by differently experienced raters;Gobbo M, Rupel K, Zoi V, Perinetti G, Ottaviani G, Di Lenarda R, Bevilacqua L, Woo SB, Biasotto M.;"Med Oral Patol Oral Cir Bucal. 2017 Sep 1;22(5):e562-e571. doi: 10.4317/medoral.21833.";Gobbo M;Med Oral Patol Oral Cir Bucal;2017;16/08/2017;PMC5694178;NA;10.4317/medoral.21833
84;29180094;Validation study of the Vitiligo Extent Score-plus;van Geel N, Wolkerstorfer A, Lommerts JE, Ezzedine K, Eleftheriadou V, Hamzavi I, Harris J, Picardo M, Taieb A, Prinsen CAC, Bekkenk M, Speeckaert R.;"J Am Acad Dermatol. 2018 May;78(5):1013-1015. doi: 10.1016/j.jaad.2017.11.032. Epub 2017 Nov 24.";van Geel N;J Am Acad Dermatol;2018;29/11/2017;NA;NA;10.1016/j.jaad.2017.11.032
85;16626381;Validation of scalp coverage scoring methods for scalp hair loss in male pattern hair loss (androgenetic alopecia);Van Neste D, Sandraps E, Herbaut D, Lelubre P, Leroy T.;"Skin Res Technol. 2006 May;12(2):89-93. doi: 10.1111/j.0909-752X.2006.00201.x.";Van Neste D;Skin Res Technol;2006;22/04/2006;NA;NA;10.1111/j.0909-752X.2006.00201.x
86;29355894;How should minimally important change scores for the Patient-Oriented Eczema Measure be interpreted? A validation using varied methods;"Howells L, Ratib S, Chalmers JR, Bradshaw L, Thomas KS; CLOTHES trial team.";"Br J Dermatol. 2018 May;178(5):1135-1142. doi: 10.1111/bjd.16367. Epub 2018 Apr 17.";Howells L;Br J Dermatol;2018;23/01/2018;PMC6001667;NA;10.1111/bjd.16367
87;8308774;Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies;Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, Silman AJ, Allegar N, Varga J, Massa M, et al.;"J Rheumatol. 1993 Nov;20(11):1892-6.";Clements PJ;J Rheumatol;1993;01/11/1993;NA;NA;NA
88;18928687;Severity scoring of atopic dermatitis: a comparison of two scoring systems;Rullo VE, Segato A, Kirsh A, Sole D.;"Allergol Immunopathol (Madr). 2008 Jul-Aug;36(4):205-11.";Rullo VE;Allergol Immunopathol (Madr);2008;22/10/2008;NA;NA;NA
89;19434791;The Birmingham Epidermolysis Bullosa Severity score: development and validation;Moss C, Wong A, Davies P.;"Br J Dermatol. 2009 May;160(5):1057-65. doi: 10.1111/j.1365-2133.2009.09041.x.";Moss C;Br J Dermatol;2009;13/05/2009;NA;NA;10.1111/j.1365-2133.2009.09041.x
90;2966711;Assessment of erythema in irritant contact dermatitis. Comparison between visual scoring and laser Doppler flowmetry;Willis CM, Stephens CJ, Wilkinson JD.;"Contact Dermatitis. 1988 Mar;18(3):138-42. doi: 10.1111/j.1600-0536.1988.tb04499.x.";Willis CM;Contact Dermatitis;1988;01/03/1988;NA;NA;10.1111/j.1600-0536.1988.tb04499.x
91;29306872;Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study;Herrick AL, Peytrignet S, Lunt M, Pan X, Hesselstrand R, Mouthon L, Silman AJ, Dinsdale G, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk MC, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jobanputra P, Jordan AC, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov NS, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, İnanç M, McLaren JS, van Laar JM, Pathare S, Proudman SM, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Denton CP.;"Ann Rheum Dis. 2018 Apr;77(4):563-570. doi: 10.1136/annrheumdis-2017-211912. Epub 2018 Jan 6.";Herrick AL;Ann Rheum Dis;2018;08/01/2018;PMC5890636;NA;10.1136/annrheumdis-2017-211912
92;22575158;Epidermolysis Bullosa Oropharyngeal Severity (EBOS) score: a multicenter development and reliability assessment;Fortuna G, Chainani-Wu N, Lozada-Nur F, Aria M, Cepeda-Valdes R, Pollio A, Marinkovich MP, Martinez-Salazar AE, Mignogna MD, Bruckner AL, Salas-Alanís JC.;"J Am Acad Dermatol. 2013 Jan;68(1):83-92. doi: 10.1016/j.jaad.2012.04.009. Epub 2012 May 8.";Fortuna G;J Am Acad Dermatol;2013;12/05/2012;NA;NA;10.1016/j.jaad.2012.04.009
93;30176092;Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group;Napolitano M, Calzavara-Pinton PG, Zanca A, Bianchi L, Caposiena Caro RD, Offidani AM, Ganzetti G, Molinelli E, Dini V, Oranges T, Romanelli M, Egan CG, Fabbrocini G, Monfrecola G, Lacarrubba F, Musumeci ML, Passoni E, Venturini M, Micali G.;"J Eur Acad Dermatol Venereol. 2019 Feb;33(2):e84-e87. doi: 10.1111/jdv.15235. Epub 2018 Sep 25.";Napolitano M;J Eur Acad Dermatol Venereol;2019;04/09/2018;NA;NA;10.1111/jdv.15235
94;7562757;Variability of skin scores and clinical measurements in scleroderma;Pope JE, Baron M, Bellamy N, Campbell J, Carette S, Chalmers I, Dales P, Hanly J, Kaminska EA, Lee P, et al.;"J Rheumatol. 1995 Jul;22(7):1271-6.";Pope JE;J Rheumatol;1995;01/07/1995;NA;NA;NA
95;21038781;Evaluation of patient's subjective severity using various scoring system in Korean children with atopic dermatitis;Yang HJ, Jeon YH, Pyun BY.;"Asian Pac J Allergy Immunol. 2010 Jun-Sep;28(2-3):130-5.";Yang HJ;Asian Pac J Allergy Immunol;2010;03/11/2010;NA;NA;NA
96;30690571;Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis;Rosina S, Consolaro A, van Dijkhuizen P, Pistorio A, Varnier GC, Bovis F, Nistala K, Maillard S, Civino A, Tsitsami E, de Inocencio J, Jelusic M, Vojinovic J, Espada G, Makay B, Katsicas MM, Pratsidou-Gertsi P, Lazarevic D, Rao AP, Pires Marafon D, Martini A, Pilkington C, Ruperto N, Ravelli A.;"Rheumatology (Oxford). 2019 Jul 1;58(7):1196-1205. doi: 10.1093/rheumatology/key421.";Rosina S;Rheumatology (Oxford);2019;29/01/2019;NA;NA;10.1093/rheumatology/key421
97;27244117;The Reliability, Validity and Responsiveness of Two Disease Scores (BPDAI and ABSIS) for Bullous Pemphigoid: Which One to Use?;Wijayanti A, Zhao CY, Boettiger D, Chiang YZ, Ishii N, Hashimoto T, Murrell DF.;"Acta Derm Venereol. 2017 Jan 4;97(1):24-31. doi: 10.2340/00015555-2473.";Wijayanti A;Acta Derm Venereol;2017;01/06/2016;NA;NA;10.2340/00015555-2473
98;27358037;Interobserver Reliability of Three Validated Scoring Systems in the Assessment of Diabetic Foot Ulcers;Forsythe RO, Ozdemir BA, Chemla ES, Jones KG, Hinchliffe RJ.;"Int J Low Extrem Wounds. 2016 Sep;15(3):213-9. doi: 10.1177/1534734616654567. Epub 2016 Jun 29.";Forsythe RO;Int J Low Extrem Wounds;2016;01/07/2016;NA;NA;10.1177/1534734616654567
99;28370513;High-dose intravenous immunoglobulin therapy for scleromyxoedema: a prospective open-label clinical trial using an objective score of clinical evaluation system;Guarneri A, Cioni M, Rongioletti F.;"J Eur Acad Dermatol Venereol. 2017 Jul;31(7):1157-1160. doi: 10.1111/jdv.14244. Epub 2017 Apr 12.";Guarneri A;J Eur Acad Dermatol Venereol;2017;04/04/2017;NA;NA;10.1111/jdv.14244
100;29297927;An Oral Disease Severity Score validated for use in oral pemphigus vulgaris;Ormond M, McParland H, Donaldson ANA, Andiappan M, Cook RJ, Escudier M, Hullah E, Higham J, McMillan R, Taylor J, Shirlaw PJ, Challacombe SJ, Setterfield JF.;"Br J Dermatol. 2018 Oct;179(4):872-881. doi: 10.1111/bjd.16265. Epub 2018 Apr 28.";Ormond M;Br J Dermatol;2018;04/01/2018;NA;NA;10.1111/bjd.16265
101;19605370;Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis--assessment of individual body sites in two large randomized controlled trials;"Kaldas M, Khanna PP, Furst DE, Clements PJ, Kee Wong W, Seibold JR, Postlethwaite AE, Khanna D; investigators of the human recombinant relaxin and oral bovine collagen clinical trials.";"Rheumatology (Oxford). 2009 Sep;48(9):1143-6. doi: 10.1093/rheumatology/kep202. Epub 2009 Jul 14.";Kaldas M;Rheumatology (Oxford);2009;17/07/2009;PMC2734267;NA;10.1093/rheumatology/kep202
102;17199681;Wound bed score and its correlation with healing of chronic wounds;Falanga V, Saap LJ, Ozonoff A.;"Dermatol Ther. 2006 Nov-Dec;19(6):383-90. doi: 10.1111/j.1529-8019.2006.00096.x.";Falanga V;Dermatol Ther;2006;04/01/2007;NA;NA;10.1111/j.1529-8019.2006.00096.x
103;17941937;Evaluation of the Cutaneous Lupus Activity and Severity Score in the assessment of lupus erythematosus skin disease;Abdel-Aziz K, Goodfield M.;"Br J Dermatol. 2008 Jan;158(1):181-2. doi: 10.1111/j.1365-2133.2007.08260.x. Epub 2007 Oct 17.";Abdel-Aziz K;Br J Dermatol;2008;19/10/2007;NA;NA;10.1111/j.1365-2133.2007.08260.x
104;16181458;The objective severity assessment of atopic dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis;Angelova-Fischer I, Bauer A, Hipler UC, Petrov I, Kazandjieva J, Bruckner T, Diepgen T, Tsankov N, Williams M, Fischer TW, Elsner P, Fluhr JW.;"Br J Dermatol. 2005 Oct;153(4):767-73. doi: 10.1111/j.1365-2133.2005.06697.x.";Angelova-Fischer I;Br J Dermatol;2005;27/09/2005;NA;NA;10.1111/j.1365-2133.2005.06697.x
105;25556325;The Atopic Dermatitis Antecubital Severity score: validity, reliability, and sensitivity to change in patients with atopic dermatitis;Baek JH, Park CW, Choi KM, Yang YS, Lee SY, Koh JS, Chung BY, Kim HO, Park GH.;"Int J Dermatol. 2015 Dec;54(12):1382-9. doi: 10.1111/ijd.12711. Epub 2014 Dec 29.";Baek JH;Int J Dermatol;2015;06/01/2015;NA;NA;10.1111/ijd.12711
106;29307645;The Vitiligo Extent Score (VES) and the VESplus are responsive instruments to assess global and regional treatment response in patients with vitiligo;van Geel N, Bekkenk M, Lommerts JE, Ezzedine K, Harris J, Hamzavi I, Eleftheriadou V, Picardo M, Taieb A, Prinsen CAC, Wolkerstorfer A, Speeckaert R.;"J Am Acad Dermatol. 2018 Aug;79(2):369-371. doi: 10.1016/j.jaad.2017.12.070. Epub 2018 Jan 4.";van Geel N;J Am Acad Dermatol;2018;09/01/2018;NA;NA;10.1016/j.jaad.2017.12.070
107;18002738;Area assessment of psoriasis lesion for PASI scoring;Ihtatho D, Fadzil MH, Affandi AM, Hussein SH.;"Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:3446-9. doi: 10.1109/IEMBS.2007.4353072.";Ihtatho D;Annu Int Conf IEEE Eng Med Biol Soc;2007;16/11/2007;NA;NA;10.1109/IEMBS.2007.4353072
108;9458208;The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis;Furst DE, Clements PJ, Steen VD, Medsger TA Jr, Masi AT, D'Angelo WA, Lachenbruch PA, Grau RG, Seibold JR.;"J Rheumatol. 1998 Jan;25(1):84-8.";Furst DE;J Rheumatol;1998;11/02/1998;NA;NA;NA
109;26616440;Assessing new terminal body and facial hair growth during pregnancy: toward developing a simplified visual scoring system for hirsutism;Yang Y, Han Y, Wang W, Du T, Li Y, Zhang J, Yang D, Zhao X.;"Fertil Steril. 2016 Feb;105(2):494-500. doi: 10.1016/j.fertnstert.2015.10.036. Epub 2015 Nov 23.";Yang Y;Fertil Steril;2016;01/12/2015;NA;NA;10.1016/j.fertnstert.2015.10.036
110;34755891;PASI vs PO-PASI: Patient-Oriented PASI (PO-PASI) is comparable to clinician score PASI;Montes de Oca Pedrosa A, Oakley A, Rogers J, Rangaitaha Epiha M.;"Australas J Dermatol. 2022 Feb;63(1):e67-e70. doi: 10.1111/ajd.13738. Epub 2021 Nov 10.";Montes de Oca Pedrosa A;Australas J Dermatol;2022;10/11/2021;NA;NA;10.1111/ajd.13738
111;33288650;Independent Observational Analysis of Ulcer Outcomes for SINBAD and University of Texas Ulcer Scoring Systems;Leese GP, Soto-Pedre E, Schofield C.;"Diabetes Care. 2021 Feb;44(2):326-331. doi: 10.2337/dc20-1817. Epub 2020 Dec 7.";Leese GP;Diabetes Care;2021;08/12/2020;NA;NA;10.2337/dc20-1817
112;30298709;Comparison of clinical and sonographic scores in hidradenitis suppurativa and proposal of a novel ultrasound scoring system;Nazzaro G, Passoni E, Muratori S, Moltrasio C, Guanziroli E, Barbareschi M, Veraldi S, Marzano AV.;"Ital J Dermatol Venerol. 2021 Apr;156(2):235-239. doi: 10.23736/S2784-8671.18.06196-5. Epub 2018 Oct 4.";Nazzaro G;Ital J Dermatol Venerol;2021;10/10/2018;NA;NA;10.23736/S2784-8671.18.06196-5
113;25493680;Cross-cultural adaptation and clinical validation of the Neonatal Skin Condition Score to Brazilian Portuguese;Schardosim JM, Ruschel LM, da Motta Gde C, da Cunha ML.;"Rev Lat Am Enfermagem. 2014 Oct;22(5):834-41. doi: 10.1590/0104-1169.3456.2487.";Schardosim JM;Rev Lat Am Enfermagem;2014;11/12/2014;PMC4292664;NA;10.1590/0104-1169.3456.2487
114;31587383;Validation of the Patient-Oriented SCORing for Atopic Dermatitis tool for black skin;Faye O, Meledie N'Djong AP, Diadie S, Coniquet S, Niamba PA, Atadokpede F, Yao Yoboue P, Thierno Dieng M, Zkik A, Castagne C, Zumaglini F, Delarue A.;"J Eur Acad Dermatol Venereol. 2020 Apr;34(4):795-799. doi: 10.1111/jdv.15999. Epub 2019 Nov 7.";Faye O;J Eur Acad Dermatol Venereol;2020;07/10/2019;PMC7154547;NA;10.1111/jdv.15999
115;29417136;A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa;Hessam S, Scholl L, Sand M, Schmitz L, Reitenbach S, Bechara FG.;"JAMA Dermatol. 2018 Mar 1;154(3):330-335. doi: 10.1001/jamadermatol.2017.5890.";Hessam S;JAMA Dermatol;2018;09/02/2018;PMC5885841;NA;10.1001/jamadermatol.2017.5890
116;26817178;Inter- and Intra-Observer Reliability of Modified Rodnan Skin Score Assessment in Thai Systemic Sclerosis Patients: A Validation for Multicenter Scleroderma Cohort Study;Foocharoen C, Thinkhamrop B, Mahakkanukrauh A, Suwannaroj S, Netwijitpan S, Sripavatakul K, Chuealee W, Boottam B, Towiwat P, Seubmee P, Daungkum K, Kongpan D, Mangkala J, Nanagara R.;"J Med Assoc Thai. 2015 Nov;98(11):1082-8.";Foocharoen C;J Med Assoc Thai;2015;29/01/2016;NA;NA;NA
117;22913528;Validation of a clinical evaluation score for irritative dermatitis: SCOREPI;Le Maître M, Crickx B, Lacour JP, Bagot M, Chevallier JM, Cribier B, Doutre MS, Giordano-Labadie F, Guillot B, Joly P, Schmutz JL, Vabres P, Bensimon D.;"J Eur Acad Dermatol Venereol. 2013 Sep;27(9):1138-42. doi: 10.1111/j.1468-3083.2012.04678.x. Epub 2012 Aug 22.";Le Maître M;J Eur Acad Dermatol Venereol;2013;24/08/2012;NA;NA;10.1111/j.1468-3083.2012.04678.x
118;28636793;Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity;"Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, Ingram JR, Kanni T, Karagiannidis I, Martorell A, Matusiak Ł, Pinter A, Prens EP, Presser D, Schneider-Burrus S, von Stebut E, Szepietowski JC, van der Zee HH, Wilden SM, Sabat R; European Hidradenitis Suppurativa Foundation Investigator Group.";"Br J Dermatol. 2017 Nov;177(5):1401-1409. doi: 10.1111/bjd.15748. Epub 2017 Oct 30.";Zouboulis CC;Br J Dermatol;2017;22/06/2017;NA;NA;10.1111/bjd.15748
119;9366834;Reliability of two methods to assess morphea: skin scoring and the use of a durometer;Seyger MM, van den Hoogen FH, de Boo T, de Jong EM.;"J Am Acad Dermatol. 1997 Nov;37(5 Pt 1):793-6. doi: 10.1016/s0190-9622(97)70121-x.";Seyger MM;J Am Acad Dermatol;1997;21/11/1997;NA;NA;10.1016/s0190-9622(97)70121-x
120;18608708;Validation of clinical and image skin scoring systems for a single chronic discoid lupus erythematosus lesion;Erceg A, De Jong EM, Van Lingen RG, De Boo TM, Van De Kerkhof PC, Seyger MM.;"J Dermatolog Treat. 2009;20(1):32-5. doi: 10.1080/09546630802155040.";Erceg A;J Dermatolog Treat;2009;09/07/2008;NA;NA;10.1080/09546630802155040
121;29341069;Reliability and validity of the instrument for scoring clinical outcomes of research for epidermolysis bullosa (iscorEB);Bruckner AL, Fairclough DL, Feinstein JA, Lara-Corrales I, Lucky AW, Tolar J, Pope E.;"Br J Dermatol. 2018 May;178(5):1128-1134. doi: 10.1111/bjd.16350. Epub 2018 Apr 2.";Bruckner AL;Br J Dermatol;2018;18/01/2018;PMC6478606;NIHMS1014728;10.1111/bjd.16350
122;17107392;Assessment of severity of hand eczema: discrepancies between patient- and physician-rated scores;van Coevorden AM, van Sonderen E, Bouma J, Coenraads PJ.;"Br J Dermatol. 2006 Dec;155(6):1217-22. doi: 10.1111/j.1365-2133.2006.07531.x.";van Coevorden AM;Br J Dermatol;2006;17/11/2006;NA;NA;10.1111/j.1365-2133.2006.07531.x
123;25868111;"The validity, reliability and acceptability of the SAVASI; a new self-assessment score in vitiligo";Komen L, van der Kraaij GE, van der Veen JP, de Rie MA, Wolkerstorfer A.;"J Eur Acad Dermatol Venereol. 2015 Nov;29(11):2145-51. doi: 10.1111/jdv.13161. Epub 2015 Apr 13.";Komen L;J Eur Acad Dermatol Venereol;2015;14/04/2015;NA;NA;10.1111/jdv.13161
124;26183969;Scoring the therapeutic effects of oral propranolol for infantile hemangioma: A prospective study comparing the Hemangioma Activity Score (HAS) with the Hemangioma Severity Scale (HSS);Janmohamed SR, van Oosterhout M, de Laat PC, van Rosmalen J, Madern GC, Oranje AP.;"J Am Acad Dermatol. 2015 Aug;73(2):258-63. doi: 10.1016/j.jaad.2015.05.012.";Janmohamed SR;J Am Acad Dermatol;2015;18/07/2015;NA;NA;10.1016/j.jaad.2015.05.012
125;22759453;Clinical scoring system for vulvar lichen sclerosus;Günthert AR, Duclos K, Jahns BG, Krause E, Amann E, Limacher A, Mueller MD, Jüni P.;"J Sex Med. 2012 Sep;9(9):2342-50. doi: 10.1111/j.1743-6109.2012.02814.x. Epub 2012 Jul 3.";Günthert AR;J Sex Med;2012;05/07/2012;NA;NA;10.1111/j.1743-6109.2012.02814.x
126;27887798;Development and validation of a patient-reported outcome measure in vitiligo: The Self Assessment Vitiligo Extent Score (SA-VES);"van Geel N, Lommerts JE, Bekkenk MW, Prinsen CA, Eleftheriadou V, Taieb A, Picardo M, Ezzedine K, Wolkerstorfer A, Speeckaert R; international Vitiligo Score Working Group.";"J Am Acad Dermatol. 2017 Mar;76(3):464-471. doi: 10.1016/j.jaad.2016.09.034. Epub 2016 Nov 22.";van Geel N;J Am Acad Dermatol;2017;27/11/2016;NA;NA;10.1016/j.jaad.2016.09.034
127;25817047;Comparison of two classification systems in predicting the outcome of diabetic foot ulcers: the Wagner grade and the Saint Elian Wound score systems;Huang Y, Xie T, Cao Y, Wu M, Yu L, Lu S, Xu G, Hu J, Ruan H.;"Wound Repair Regen. 2015 May-Jun;23(3):379-85. doi: 10.1111/wrr.12289.";Huang Y;Wound Repair Regen;2015;31/03/2015;NA;NA;10.1111/wrr.12289
128;33420020;Disease risk scores for skin cancers;"Fontanillas P, Alipanahi B, Furlotte NA, Johnson M, Wilson CH; 23andMe Research Team, Pitts SJ, Gentleman R, Auton A.";"Nat Commun. 2021 Jan 8;12(1):160. doi: 10.1038/s41467-020-20246-5.";Fontanillas P;Nat Commun;2021;09/01/2021;PMC7794415;NA;10.1038/s41467-020-20246-5
129;30085324;Achieving Hidradenitis Suppurativa Response Score is Associated with Significant Improvement in Clinical and Patient-reported Outcomes: Post Hoc Analysis of Pooled Data From PIONEER I and II;Kimball AB, Tzellos T, Calimlim BM, Teixeira HD, Geng Z, Okun MM.;"Acta Derm Venereol. 2018 Nov 5;98(10):932-937. doi: 10.2340/00015555-3012.";Kimball AB;Acta Derm Venereol;2018;08/08/2018;NA;NA;10.2340/00015555-3012
130;11028863;Comparison of severity scoring of atopic dermatitis values and serum levels of eosinophil cationic protein and mast cell tryptase for routine evaluation of atopic dermatitis;Amon U, Memmel U, Stoll R, Amon S.;"Acta Derm Venereol. 2000 Jul-Aug;80(4):284-6. doi: 10.1080/000155500750012180.";Amon U;Acta Derm Venereol;2000;12/10/2000;NA;NA;10.1080/000155500750012180
131;11168575;The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group;Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M.;"Exp Dermatol. 2001 Feb;10(1):11-8. doi: 10.1034/j.1600-0625.2001.100102.x.";Hanifin JM;Exp Dermatol;2001;13/02/2001;NA;NA;10.1034/j.1600-0625.2001.100102.x
132;31513501;Person-Centred Dermatology Self-care Index: a translation and validation study;Kottner J, Ludwig O, Bode T, Cowdell F, Ersser S, Blume-Peytavi U, Lahmann N.;"J Wound Care. 2019 Sep 2;28(9):566-575. doi: 10.12968/jowc.2019.28.9.566.";Kottner J;J Wound Care;2019;13/09/2019;NA;NA;10.12968/jowc.2019.28.9.566
133;28644904;Sustained Psoriasis Area and Severity Index, Dermatology Life Quality Index and EuroQol-5D response of biological treatment in psoriasis: 10 years of real-world data in the Swedish National Psoriasis Register;Hjalte F, Carlsson KS, Schmitt-Egenolf M.;"Br J Dermatol. 2018 Jan;178(1):245-252. doi: 10.1111/bjd.15757. Epub 2018 Jan 9.";Hjalte F;Br J Dermatol;2018;24/06/2017;NA;NA;10.1111/bjd.15757
134;28342225;Japanese version of the Family Dermatology Life Quality Index: Translation and validation;Higaki Y, Tanaka M, Futei Y, Kamo T, Basra MKA, Finlay AY.;"J Dermatol. 2017 Aug;44(8):914-919. doi: 10.1111/1346-8138.13831. Epub 2017 Mar 24.";Higaki Y;J Dermatol;2017;26/03/2017;NA;NA;10.1111/1346-8138.13831
135;30307024;Measuring Patient Needs and Benefits in Dermatology using the Patient Benefit Index 2.0: A Validation Study;Topp J, Augustin M, von Usslar K, Gosau R, Reich K, Reusch M, Blome C.;"Acta Derm Venereol. 2019 Feb 1;99(2):211-217. doi: 10.2340/00015555-3063.";Topp J;Acta Derm Venereol;2019;12/10/2018;NA;NA;10.2340/00015555-3063
136;33179879;Correlation study between clinical classification and disability index in a holistic evaluation of acne severity and impact in Turkey;Ozlu E, Karadag AS, Aksoy B, Gunes Bilgili S, Gonul M, Yavuz IH, Senel E, Polat M, Akbulut TO, Aksu D, Topaloglu F, Tekin B, Chen WC.;"Ital J Dermatol Venerol. 2021 Dec;156(6):669-674. doi: 10.23736/S2784-8671.20.06738-3. Epub 2020 Nov 12.";Ozlu E;Ital J Dermatol Venerol;2021;12/11/2020;NA;NA;10.23736/S2784-8671.20.06738-3
137;31009616;Validation and Interpretation of Short Form 12 and Comparison with Dermatology Life Quality Index in Atopic Dermatitis in Adults;Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Chiesa Fuxench ZC, Simpson EL.;"J Invest Dermatol. 2019 Oct;139(10):2090-2097.e3. doi: 10.1016/j.jid.2019.03.1152. Epub 2019 Apr 19.";Silverberg JI;J Invest Dermatol;2019;23/04/2019;NA;NA;10.1016/j.jid.2019.03.1152
138;22284147;Clinical meaning in skin-specific quality of life instruments: a comparison of the Dermatology Life Quality Index and Skindex banding systems;Rogers A, DeLong LK, Chen SC.;"Dermatol Clin. 2012 Apr;30(2):333-42, x. doi: 10.1016/j.det.2011.11.010.";Rogers A;Dermatol Clin;2012;31/01/2012;NA;NA;10.1016/j.det.2011.11.010
139;30484524;Translation and validation of the Simplified Psoriasis Index (SPI) into Brazilian Portuguese;Morais MR, Martins GA, Romiti R, Tonoli RE, Carvalho AVE.;"An Bras Dermatol. 2018 Nov/Dec;93(6):813-818. doi: 10.1590/abd1806-4841.20186477.";Morais MR;An Bras Dermatol;2018;29/11/2018;PMC6256203;NA;10.1590/abd1806-4841.20186477
140;21603812;Validation of the commitment index of skin and mucous membranes in pemphigus vulgaris for the clinical evaluation of patients with pemphigus vulgaris;Souza SR, Azulay-Abulafia L, Nascimento LV.;"An Bras Dermatol. 2011 Mar-Apr;86(2):284-91. doi: 10.1590/s0365-05962011000200012.";Souza SR;An Bras Dermatol;2011;24/05/2011;NA;NA;10.1590/s0365-05962011000200012
141;23897275;Responsiveness to change and interpretability of the simplified psoriasis index;Chularojanamontri L, Griffiths CEM, Chalmers RJG.;"J Invest Dermatol. 2014 Feb;134(2):351-358. doi: 10.1038/jid.2013.318. Epub 2013 Jul 29.";Chularojanamontri L;J Invest Dermatol;2014;31/07/2013;NA;NA;10.1038/jid.2013.318
142;16875475;Development of the facial skin care index: a health-related outcomes index for skin cancer patients;Matthews BA, Rhee JS, Neuburg M, Burzynski ML, Nattinger AB.;"Dermatol Surg. 2006 Jul;32(7):924-34; discussion 934. doi: 10.1111/j.1524-4725.2006.32197.x.";Matthews BA;Dermatol Surg;2006;01/08/2006;PMC1810190;NIHMS12872;10.1111/j.1524-4725.2006.32197.x
143;22229951;Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis;Fernandez-Peñas P, Jones-Caballero M, Espallardo O, García-Díez A.;"Br J Dermatol. 2012 Apr;166(4):884-7. doi: 10.1111/j.1365-2133.2012.10806.x.";Fernandez-Peñas P;Br J Dermatol;2012;11/01/2012;NA;NA;10.1111/j.1365-2133.2012.10806.x
144;27730628;Assessing the validity and response distribution of the simplified psoriasis index in patients receiving phototherapy;Meah N, Alsharqi A, Azurdia RM, Owens LC, Parslew R, Chularojanamontri L.;"Australas J Dermatol. 2018 Feb;59(1):41-47. doi: 10.1111/ajd.12549. Epub 2016 Oct 12.";Meah N;Australas J Dermatol;2018;13/10/2016;NA;NA;10.1111/ajd.12549
145;27718521;Validation of the Simplified Psoriasis Index in Dutch children and adolescents with plaque psoriasis;van Geel MJ, Otero ME, de Jong EM, van de Kerkhof PC, Seyger MM.;"Br J Dermatol. 2017 Mar;176(3):771-776. doi: 10.1111/bjd.15120. Epub 2016 Dec 8.";van Geel MJ;Br J Dermatol;2017;09/10/2016;NA;NA;10.1111/bjd.15120
146;23165828;The Person-Centered Dermatology Self-Care Index: a tool to measure education and support needs of patients with long-term skin conditions;Cowdell F, Ersser SJ, Gradwell C, Thomas PW.;"Arch Dermatol. 2012 Nov;148(11):1251-5. doi: 10.1001/archdermatol.2012.1892.";Cowdell F;Arch Dermatol;2012;21/11/2012;NA;NA;10.1001/archdermatol.2012.1892
147;20107723;How robust are the Dermatology Life Quality Index and other self-reported subjective symptom scores when exposed to a range of experimental biases?;Murray CS, Rees JL.;"Acta Derm Venereol. 2010;90(1):34-8. doi: 10.2340/00015555-0768.";Murray CS;Acta Derm Venereol;2010;29/01/2010;NA;NA;10.2340/00015555-0768
148;23278616;Dermatology life quality index scores in children with vitiligo: comparison with atopic dermatitis and healthy control subjects;Dertlioglu SB, Cicek D, Balci DD, Halisdemir N.;"Int J Dermatol. 2013 Jan;52(1):96-101. doi: 10.1111/j.1365-4632.2012.05616.x.";Dertlioglu SB;Int J Dermatol;2013;03/01/2013;NA;NA;10.1111/j.1365-4632.2012.05616.x
149;12932238;Sensitivity of the Dermatology Life Quality Index to clinical change in patients with psoriasis;"Mazzotti E, Picardi A, Sampogna F, Sera F, Pasquini P, Abeni D; IDI Multipurpose Psoriasis Research on Vital Experiences study group.";"Br J Dermatol. 2003 Aug;149(2):318-22. doi: 10.1046/j.1365-2133.2003.05378.x.";Mazzotti E;Br J Dermatol;2003;23/08/2003;NA;NA;10.1046/j.1365-2133.2003.05378.x
150;15868618;Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial;"Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, Korn JH, Merkel PA, Rothfield N, Wigley FM, Moreland LW, Silver R, Steen VD, Weisman M, Mayes MD, Collier DH, Medsger TA Jr, Seibold JR; Relaxin Study Group; Scleroderma Clinical Trials Consortium.";"J Rheumatol. 2005 May;32(5):832-40.";Khanna D;J Rheumatol;2005;04/05/2005;NA;NA;NA
151;30803689;Absolute Versus Relative Psoriasis Area and Severity Index in Clinical Practice;Del Alcázar Viladomiu E, Lamas Doménech N, Salleras Redonnet M.;"Actas Dermosifiliogr (Engl Ed). 2019 Sep;110(7):606-610. doi: 10.1016/j.ad.2018.03.029. Epub 2019 Feb 23.";Del Alcázar Viladomiu E;Actas Dermosifiliogr (Engl Ed);2019;27/02/2019;NA;NA;10.1016/j.ad.2018.03.029
152;23772081;Use of the Patient-generated Index in systemic sclerosis to assess patient-centered outcomes;de Achaval S, Kallen MA, Mayes MD, Lopez-Olivo MA, Suarez-Almazor ME.;"J Rheumatol. 2013 Aug;40(8):1337-43. doi: 10.3899/jrheum.120978. Epub 2013 Jun 15.";de Achaval S;J Rheumatol;2013;18/06/2013;PMC3888061;NIHMS541720;10.3899/jrheum.120978
153;12890862;The Behcet's disease activity index;Lawton G, Bhakta BB, Chamberlain MA, Tennant A.;"Rheumatology (Oxford). 2004 Jan;43(1):73-8. doi: 10.1093/rheumatology/keg453. Epub 2003 Jul 30.";Lawton G;Rheumatology (Oxford);2004;02/08/2003;NA;NA;10.1093/rheumatology/keg453
154;17958869;A comparative study of the Children's Dermatology Life Quality Index (CDLQI) in paediatric dermatology clinics in the UK and Bulgaria;Clayton TH, Clark SM, Britton J, Pavlov S, Radev S.;"J Eur Acad Dermatol Venereol. 2007 Nov;21(10):1436-7. doi: 10.1111/j.1468-3083.2007.02249.x.";Clayton TH;J Eur Acad Dermatol Venereol;2007;26/10/2007;NA;NA;10.1111/j.1468-3083.2007.02249.x
155;31228524;Validation of the electronic Psoriasis Area and Severity Index application: Establishing measurement equivalence;Ali FM, Salek S, Finlay AY, Piguet V.;"J Am Acad Dermatol. 2019 Dec;81(6):1439-1441. doi: 10.1016/j.jaad.2019.04.073. Epub 2019 Jun 19.";Ali FM;J Am Acad Dermatol;2019;23/06/2019;NA;NA;10.1016/j.jaad.2019.04.073
156;25542903;Validity and reliability of the Lupus QoL index in Turkish systemic lupus erythematosus patients;Pamuk ON, Onat AM, Donmez S, Mengüs C, Kisacik B.;"Lupus. 2015 Jul;24(8):816-21. doi: 10.1177/0961203314565412. Epub 2014 Dec 26.";Pamuk ON;Lupus;2015;28/12/2014;NA;NA;10.1177/0961203314565412
157;12430733;The Norwegian version of the dermatology life quality index: a study of validity and reliability in psoriatics;Mørk C, Wahl A, Moum T.;"Acta Derm Venereol. 2002;82(5):347-51. doi: 10.1080/000155502320624078.";Mørk C;Acta Derm Venereol;2002;15/11/2002;NA;NA;10.1080/000155502320624078
158;12588405;Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome;Parsad D, Pandhi R, Dogra S, Kanwar AJ, Kumar B.;"Br J Dermatol. 2003 Feb;148(2):373-4. doi: 10.1046/j.1365-2133.2003.05097_9.x.";Parsad D;Br J Dermatol;2003;18/02/2003;NA;NA;10.1046/j.1365-2133.2003.05097_9.x
159;11167690;The Infants' Dermatitis Quality of Life Index;Lewis-Jones MS, Finlay AY, Dykes PJ.;"Br J Dermatol. 2001 Jan;144(1):104-10. doi: 10.1046/j.1365-2133.2001.03960.x.";Lewis-Jones MS;Br J Dermatol;2001;13/02/2001;NA;NA;10.1046/j.1365-2133.2001.03960.x
160;21881588;Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis?;Twiss J, Meads DM, Preston EP, Crawford SR, McKenna SP.;"J Invest Dermatol. 2012 Jan;132(1):76-84. doi: 10.1038/jid.2011.238. Epub 2011 Sep 1.";Twiss J;J Invest Dermatol;2012;02/09/2011;NA;NA;10.1038/jid.2011.238
161;16159732;Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis;Mazzotti E, Barbaranelli C, Picardi A, Abeni D, Pasquini P.;"Acta Derm Venereol. 2005;85(5):409-13. doi: 10.1080/00015550510032832.";Mazzotti E;Acta Derm Venereol;2005;15/09/2005;NA;NA;10.1080/00015550510032832
162;18671781;Validation of the Dermatology Life Quality Index among patients with podoconiosis in southern Ethiopia;Henok L, Davey G.;"Br J Dermatol. 2008 Sep;159(4):903-6. doi: 10.1111/j.1365-2133.2008.08773.x. Epub 2008 Jul 30.";Henok L;Br J Dermatol;2008;02/08/2008;NA;NA;10.1111/j.1365-2133.2008.08773.x
163;21115550;Development of a preliminary composite disease activity index in psoriatic arthritis;Mumtaz A, Gallagher P, Kirby B, Waxman R, Coates LC, Veale J D, Helliwell P, FitzGerald O.;"Ann Rheum Dis. 2011 Feb;70(2):272-7. doi: 10.1136/ard.2010.129379. Epub 2010 Nov 29.";Mumtaz A;Ann Rheum Dis;2011;01/12/2010;NA;NA;10.1136/ard.2010.129379
164;18759896;The validity and reliability of the occupational contact dermatitis disease severity index;Curr N, Dharmage S, Keegel T, Lee A, Saunders H, Nixon R.;"Contact Dermatitis. 2008 Sep;59(3):157-64. doi: 10.1111/j.1600-0536.2008.01404.x.";Curr N;Contact Dermatitis;2008;02/09/2008;NA;NA;10.1111/j.1600-0536.2008.01404.x
165;22007701;Qualitative assessment of the content validity of the Dermatology Life Quality Index in patients with moderate to severe psoriasis;Safikhani S, Sundaram M, Bao Y, Mulani P, Revicki DA.;"J Dermatolog Treat. 2013 Feb;24(1):50-9. doi: 10.3109/09546634.2011.631980. Epub 2011 Nov 10.";Safikhani S;J Dermatolog Treat;2013;20/10/2011;NA;NA;10.3109/09546634.2011.631980
166;12588381;The Children's Dermatology Life Quality Index: validation of the cartoon version;Holme SA, Man I, Sharpe JL, Dykes PJ, Lewis-Jones MS, Finlay AY.;"Br J Dermatol. 2003 Feb;148(2):285-90. doi: 10.1046/j.1365-2133.2003.05157.x.";Holme SA;Br J Dermatol;2003;18/02/2003;NA;NA;10.1046/j.1365-2133.2003.05157.x
167;29609220;Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis;Wervers K, Vis M, Tchetveriko I, Gerards AH, Kok MR, Appels CWY, van der Graaff WL, van Groenendael JHLM, Korswagen LA, Veris-van Dieren JJ, Hazes JMW, Luime JJ.;"Arthritis Care Res (Hoboken). 2018 Dec;70(12):1764-1770. doi: 10.1002/acr.23571.";Wervers K;Arthritis Care Res (Hoboken);2018;03/04/2018;PMC6587485;NA;10.1002/acr.23571
168;22500772;Reliability and validity of the Chinese version of the Psoriasis Disability Index (PDI) in Chinese patients with psoriasis;He Z, Lu C, Ou A, Fang J, Wang D, Deng J, Zhang Z, Yu J.;"Health Qual Life Outcomes. 2012 Apr 13;10:37. doi: 10.1186/1477-7525-10-37.";He Z;Health Qual Life Outcomes;2012;17/04/2012;PMC3464895;NA;10.1186/1477-7525-10-37
169;19614861;A composite index for determining the impact of oral ulcer activity in Behcet's disease and recurrent aphthous stomatitis;Mumcu G, Sur H, Inanc N, Karacayli U, Cimilli H, Sisman N, Ergun T, Direskeneli H.;"J Oral Pathol Med. 2009 Nov;38(10):785-91. doi: 10.1111/j.1600-0714.2009.00803.x. Epub 2009 Jul 15.";Mumcu G;J Oral Pathol Med;2009;21/07/2009;NA;NA;10.1111/j.1600-0714.2009.00803.x
170;15328673;Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life;Lennox RD, Leahy MJ.;"Ann Allergy Asthma Immunol. 2004 Aug;93(2):142-6. doi: 10.1016/S1081-1206(10)61466-4.";Lennox RD;Ann Allergy Asthma Immunol;2004;27/08/2004;NA;NA;10.1016/S1081-1206(10)61466-4
171;15818719;The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: an evaluation of their measurement properties;Johnson SR, Hawker GA, Davis AM.;"Arthritis Rheum. 2005 Apr 15;53(2):256-62. doi: 10.1002/art.21084.";Johnson SR;Arthritis Rheum;2005;09/04/2005;NA;NA;10.1002/art.21084
172;14651564;Validation of a Cantonese version of the Children's Dermatology Life Quality Index;Chuh AA.;"Pediatr Dermatol. 2003 Nov-Dec;20(6):479-81. doi: 10.1111/j.1525-1470.2003.20604.x.";Chuh AA;Pediatr Dermatol;2003;04/12/2003;NA;NA;10.1111/j.1525-1470.2003.20604.x
173;25054747;Translation, cultural adaptation, and validation of the American Skindex-29 quality of life index;Paula HR, Haddad A, Weiss MA, Dini GM, Ferreira LM.;"An Bras Dermatol. 2014 Jul-Aug;89(4):600-7. doi: 10.1590/abd1806-4841.20142453.";Paula HR;An Bras Dermatol;2014;24/07/2014;PMC4148274;NA;10.1590/abd1806-4841.20142453
174;19317950;Practical understanding of mean percent psoriasis area and severity index reduction for biologics;English PL, Vender R.;"J Cutan Med Surg. 2008 Nov-Dec;12(6):282-7. doi: 10.2310/7750.2008.07079.";English PL;J Cutan Med Surg;2008;26/03/2009;NA;NA;10.2310/7750.2008.07079
175;16734506;The Acne Quality of Life Index (Acne-QOLI): development and validation of a brief instrument;Rapp SR, Feldman SR, Graham G, Fleischer AB, Brenes G, Dailey M.;"Am J Clin Dermatol. 2006;7(3):185-92. doi: 10.2165/00128071-200607030-00005.";Rapp SR;Am J Clin Dermatol;2006;01/06/2006;NA;NA;10.2165/00128071-200607030-00005
176;21576955;Practical issues on interpretation of scoring atopic dermatitis: SCORAD Index, objective SCORAD, patient-oriented SCORAD and Three-Item Severity score;Oranje AP.;"Curr Probl Dermatol. 2011;41:149-155. doi: 10.1159/000323308. Epub 2011 May 12.";Oranje AP;Curr Probl Dermatol;2011;18/05/2011;NA;NA;10.1159/000323308
177;28853494;Assessment of Quality of Life in Chronic Pruritus: Relationship Between ItchyQoL and Dermatological Life Quality Index in 1,150 Patients;Stumpf A, Pfleiderer B, Fritz F, Osada N, Chen SC, Ständer S.;"Acta Derm Venereol. 2018 Jan 12;98(1):142-143. doi: 10.2340/00015555-2782.";Stumpf A;Acta Derm Venereol;2018;31/08/2017;NA;NA;10.2340/00015555-2782
178;27393576;Sensitivity to change of the Dermatology Life Quality Index in adult females with facial acne vulgaris: a validation study;Richter C, Trojahn C, Hillmann K, Dobos G, Kanti V, Vogt A, Blume-Peytavi U, Kottner J.;"J Eur Acad Dermatol Venereol. 2017 Jan;31(1):169-174. doi: 10.1111/jdv.13757. Epub 2016 Jul 9.";Richter C;J Eur Acad Dermatol Venereol;2017;10/07/2016;NA;NA;10.1111/jdv.13757
179;16972158;Condensation and validation of a 4-item index of the Acne-QoL;Tan J, Fung KY, Khan S.;"Qual Life Res. 2006 Sep;15(7):1203-10. doi: 10.1007/s11136-006-0063-3. Epub 2006 Sep 13.";Tan J;Qual Life Res;2006;15/09/2006;NA;NA;10.1007/s11136-006-0063-3
180;25358871;To what extent is quality of life impaired in vitiligo? A multicenter study on Italian patients using the dermatology life quality index;Ingordo V, Cazzaniga S, Medri M, Raone B, Digiuseppe MD, Musumeci ML, Romano I, Fai D, Pellegrino M, Pezzarossa E, Di Lernia V, Peccerillo F, Battarra VC, Sirna R, Patrizi A, Naldi L.;"Dermatology. 2014;229(3):240-7. doi: 10.1159/000363407. Epub 2014 Oct 25.";Ingordo V;Dermatology;2014;01/11/2014;NA;NA;10.1159/000363407
181;12918681;The Behçet's disease activity index;Lawton G, Chamberlain MA, Bhakta BB, Tennant A.;"Adv Exp Med Biol. 2003;528:149-51. doi: 10.1007/0-306-48382-3_30.";Lawton G;Adv Exp Med Biol;2003;16/08/2003;NA;NA;10.1007/0-306-48382-3_30
182;17610643;Scaled Healing Assessment Index: a novel method for measuring the degree of wound bed preparation;Shai A, Avrin V, Zvulunov A, Dinstein I.;"Skin Res Technol. 2007 Aug;13(3):227-35. doi: 10.1111/j.1600-0846.2007.00215.x.";Shai A;Skin Res Technol;2007;06/07/2007;NA;NA;10.1111/j.1600-0846.2007.00215.x
183;8706393;Evaluation of patch test results by use of the reaction index. An analysis of data recorded by the Information Network of Departments of Dermatology (IVDK);Brasch J, Geier J, Henseler T.;"Contact Dermatitis. 1995 Dec;33(6):375-80. doi: 10.1111/j.1600-0536.1995.tb02070.x.";Brasch J;Contact Dermatitis;1995;01/12/1995;NA;NA;10.1111/j.1600-0536.1995.tb02070.x
184;1463945;Venous leg ulcers: a prognostic index to predict time to healing;Skene AI, Smith JM, Doré CJ, Charlett A, Lewis JD.;"BMJ. 1992 Nov 7;305(6862):1119-21. doi: 10.1136/bmj.305.6862.1119.";Skene AI;BMJ;1992;07/11/1992;PMC1883694;NA;10.1136/bmj.305.6862.1119
185;10617218;The MOAHLFA index in 17 centers of the Information Network of Departments of Dermatology (IVDK) over 6 years;Uter W, Geier J, Schnuch A.;"Contact Dermatitis. 1999 Dec;41(6):343-4. doi: 10.1111/j.1600-0536.1999.tb06186.x.";Uter W;Contact Dermatitis;1999;05/01/2000;NA;NA;10.1111/j.1600-0536.1999.tb06186.x
186;9640555;Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders;Gupta MA, Gupta AK, Watteel GN.;"Cutis. 1998 Jun;61(6):339-42.";Gupta MA;Cutis;1998;26/06/1998;NA;NA;NA
187;29894010;Using a novel scoring system for paronychia related to oncologic treatments (SPOT) for assessing paronychia severity and its correlation with pain index and quality of life;Ho PH, Lin IC, Yang X, Cho YT, Chu CY.;"J Eur Acad Dermatol Venereol. 2019 Jan;33(1):204-212. doi: 10.1111/jdv.15121. Epub 2018 Jul 6.";Ho PH;J Eur Acad Dermatol Venereol;2019;13/06/2018;NA;NA;10.1111/jdv.15121
188;19295185;The psoriasis family index: preliminary results of validation of a quality of life instrument for family members of patients with psoriasis;Eghlileb AM, Basra MK, Finlay AY.;"Dermatology. 2009;219(1):63-70. doi: 10.1159/000209234. Epub 2009 Mar 13.";Eghlileb AM;Dermatology;2009;20/03/2009;NA;NA;10.1159/000209234
189;15606650;The MOAHLFA index of irritant sodium lauryl sulfate reactions: first results of a multicentre study on routine sodium lauryl sulfate patch testing;Uter W, Geier J, Becker D, Brasch J, Löffler H.;"Contact Dermatitis. 2004 Nov-Dec;51(5-6):259-62. doi: 10.1111/j.0105-1873.2004.00458.x.";Uter W;Contact Dermatitis;2004;21/12/2004;NA;NA;10.1111/j.0105-1873.2004.00458.x
190;32501790;Assessment of Life Quality Index and Treatment Efficacy in Psoriasis Vulgaris Patients Receiving Biologic Therapies in a Turkish Population;Gundogdu M, Kundakci N, Erdem C.;"Skinmed. 2020 Mar 1;18(2):84-90. eCollection 2020.";Gundogdu M;Skinmed;2020;06/06/2020;NA;NA;NA
191;31856935;Oral ulcer activity assessment with the composite index according to different treatment modalities in Behçet's syndrome: a multicentre study;Mumcu G, Karacayli Ü, Yay M, Aksoy A, Tas MN, Armagan B, Sari A, Bozca BC, Tekgöz E, Karadag DT, Badak SÖ, Tecer D, Bes C, Sahin A, Erken E, Cefle A, Çinar M, Yilmaz S, Alpsoy E, Senel S, Bilge SY, Kasifoglu T, Karadag Ö, Aksu K, Keser G, Alibaz-Öner F, Inanç N, Ergun T, Direskeneli H.;"Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):98-104. Epub 2019 Dec 9.";Mumcu G;Clin Exp Rheumatol;2019;21/12/2019;NA;NA;NA
192;30801771;Reliability assessment and validation of the dermal pigmentation area and severity index: a new scoring method for acquired dermal macular hyperpigmentation;Kumaran MS, Dabas G, Vinay K, Parsad D.;"J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1386-1392. doi: 10.1111/jdv.15516. Epub 2019 Apr 15.";Kumaran MS;J Eur Acad Dermatol Venereol;2019;26/02/2019;NA;NA;10.1111/jdv.15516
193;22722916;Validation of the patient benefit index for the assessment of patient-relevant benefit in the treatment of psoriasis;Feuerhahn J, Blome C, Radtke M, Augustin M.;"Arch Dermatol Res. 2012 Aug;304(6):433-41. doi: 10.1007/s00403-012-1256-y. Epub 2012 Jun 22.";Feuerhahn J;Arch Dermatol Res;2012;23/06/2012;NA;NA;10.1007/s00403-012-1256-y
194;33495058;Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study;Imafuku S, Kanai Y, Murotani K, Nomura T, Ito K, Ohata C, Yamazaki F, Miyagi T, Takahashi H, Okubo Y, Saeki H, Honma M, Tada Y, Mabuchi T, Higashiyama M, Kobayashi S, Hashimoto Y, Seishima M, Kakuma T.;"J Dermatol Sci. 2021 Mar;101(3):185-193. doi: 10.1016/j.jdermsci.2021.01.002. Epub 2021 Jan 7.";Imafuku S;J Dermatol Sci;2021;26/01/2021;NA;NA;10.1016/j.jdermsci.2021.01.002
195;29776016;Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study;Talamonti M, Galluzzo M, Bernardini N, Caldarola G, Persechino S, Cantoresi F, Egan CG, Potenza C, Peris K, Bianchi L.;"J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1737-1744. doi: 10.1111/jdv.15077. Epub 2018 Jun 1.";Talamonti M;J Eur Acad Dermatol Venereol;2018;19/05/2018;NA;NA;10.1111/jdv.15077
196;32974986;Measuring perceived benefit and disease-related burden in patients affected with vulvar lichen sclerosus after a standard topical corticosteroid treatment. Results from a cohort study using Pictorial Representation of Illness and Self-measure and Dermatology Life Quality Index;Borghi A, Odorici G, Scuderi V, Valpiani G, Morotti C, Corazza M.;"Dermatol Ther. 2020 Nov;33(6):e14334. doi: 10.1111/dth.14334. Epub 2020 Oct 5.";Borghi A;Dermatol Ther;2020;25/09/2020;NA;NA;10.1111/dth.14334
197;30218575;Precision and reproducibility of automated computer-guided Psoriasis Area and Severity Index measurements in comparison with trained physicians;Fink C, Alt C, Uhlmann L, Klose C, Enk A, Haenssle HA.;"Br J Dermatol. 2019 Feb;180(2):390-396. doi: 10.1111/bjd.17200. Epub 2018 Oct 14.";Fink C;Br J Dermatol;2019;16/09/2018;NA;NA;10.1111/bjd.17200
198;32349565;Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trials;Gordon KB, Reich K, Crowley JJ, Korman NJ, Murphy FT, Poulin Y, Spelman L, Yamauchi PS, Mendelsohn AM, Parno J, Rozzo SJ, Ellis CN.;"J Dermatolog Treat. 2022 Feb;33(1):219-228. doi: 10.1080/09546634.2020.1747590. Epub 2020 Apr 30.";Gordon KB;J Dermatolog Treat;2022;01/05/2020;NA;NA;10.1080/09546634.2020.1747590
199;25994337;Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical change;Anyanwu CO, Fiorentino DF, Chung L, Dzuong C, Wang Y, Okawa J, Carr K, Propert KJ, Werth VP.;"Br J Dermatol. 2015 Oct;173(4):969-74. doi: 10.1111/bjd.13915. Epub 2015 Aug 11.";Anyanwu CO;Br J Dermatol;2015;22/05/2015;PMC4878996;NIHMS693325;10.1111/bjd.13915
200;34076919;Complete clearance and Psoriasis Area and Severity Index response for brodalumab and ustekinumab by previous treatment history in AMAGINE-2 and AMAGINE-3;Reich K, Hansen JB, Puig L, Konstantinou MP, Warren RB.;"J Eur Acad Dermatol Venereol. 2021 Oct;35(10):2034-2044. doi: 10.1111/jdv.17433. Epub 2021 Jul 24.";Reich K;J Eur Acad Dermatol Venereol;2021;02/06/2021;NA;NA;10.1111/jdv.17433
201;28129675;The objective Psoriasis Area and Severity Index: a randomized controlled pilot study comparing the effectiveness of ciclosporin and methotrexate;Choi CW, Kim BR, Seo E, Youn SW.;"Br J Dermatol. 2017 Dec;177(6):1740-1741. doi: 10.1111/bjd.15350. Epub 2017 Oct 6.";Choi CW;Br J Dermatol;2017;28/01/2017;NA;NA;10.1111/bjd.15350
202;9260216;Scoring of atopic dermatitis by SCORAD using a training atlas by investigators from different disciplines. ETAC Study Group. Early Treatment of the Atopic Child;Oranje AP, Stalder JF, Taïeb A, Tasset C, de Longueville M.;"Pediatr Allergy Immunol. 1997 Feb;8(1):28-34. doi: 10.1111/j.1399-3038.1997.tb00139.x.";Oranje AP;Pediatr Allergy Immunol;1997;01/02/1997;NA;NA;10.1111/j.1399-3038.1997.tb00139.x
203;14744406;Multiple patch-test reactions: a pilot evaluation of a combination approach to visualize patterns of multiple sensitivity in patch-test databases and a proposal for a multiple sensitivity index;Dickel H, Taylor JS, Bickers DR, Merk HF, Bruckner TM.;"Am J Contact Dermat. 2003 Sep;14(3):148-53. doi: 10.2310/6620.2003.6166.";Dickel H;Am J Contact Dermat;2003;28/01/2004;NA;NA;10.2310/6620.2003.6166
204;32510573;Hyperhidrosis Quality of Life Index (HidroQoL©): further validation and clinical application in patients with axillary hyperhidrosis using data from a phase III randomized controlled trial;Gabes M, Jourdan C, Schramm K, Masur C, Abels C, Kamudoni P, Salek S, Apfelbacher C.;"Br J Dermatol. 2021 Mar;184(3):473-481. doi: 10.1111/bjd.19300. Epub 2020 Sep 1.";Gabes M;Br J Dermatol;2021;09/06/2020;NA;NA;10.1111/bjd.19300
205;14996098;A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD);Whalley D, McKenna SP, Dewar AL, Erdman RA, Kohlmann T, Niero M, Cook SA, Crickx B, Herdman MJ, Frech F, Van Assche D.;"Br J Dermatol. 2004 Feb;150(2):274-83. doi: 10.1111/j.1365-2133.2004.05783.x.";Whalley D;Br J Dermatol;2004;05/03/2004;NA;NA;10.1111/j.1365-2133.2004.05783.x
206;12522383;Validation of the Dermatology Life Quality Index and the Work Productivity and Activity Impairment-Chronic Hand Dermatitis questionnaire in chronic hand dermatitis;Reilly MC, Lavin PT, Kahler KH, Pariser DM.;"J Am Acad Dermatol. 2003 Jan;48(1):128-30. doi: 10.1067/mjd.2003.128.";Reilly MC;J Am Acad Dermatol;2003;11/01/2003;NA;NA;10.1067/mjd.2003.128
207;16826439;Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patients;Cole JC, Khanna D, Clements PJ, Seibold JR, Tashkin DP, Paulus HE, Irwin MR, Motivala SJ, Furst DE.;"Qual Life Res. 2006 Oct;15(8):1383-94. doi: 10.1007/s11136-006-0018-8. Epub 2006 Jul 7.";Cole JC;Qual Life Res;2006;11/07/2006;NA;NA;10.1007/s11136-006-0018-8
208;28421601;Evaluation of the reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index and the Cutaneous Assessment Tool-Binary Method in juvenile dermatomyositis among paediatric dermatologists, rheumatologists and neurologists;Tiao J, Feng R, Berger EM, Brandsema JF, Coughlin CC, Khan N, Kichula EA, Lerman MA, Lvovich S, McMahon PJ, Rider LG, Rubin AI, Scalzi LV, Smith DM, Taxter AJ, Treat JR, Williams RP, Yum SW, Okawa J, Werth VP.;"Br J Dermatol. 2017 Oct;177(4):1086-1092. doi: 10.1111/bjd.15596. Epub 2017 Jul 31.";Tiao J;Br J Dermatol;2017;20/04/2017;PMC5648622;NIHMS875632;10.1111/bjd.15596
209;23948032;"Hand eczema and health-related quality of life; a comparison of EQ-5D and the Dermatology Life Quality Index (DLQI) in relation to the Hand Eczema Extent Score (HEES)";Lindberg M, Bingefors K, Meding B, Berg M.;"Contact Dermatitis. 2013 Sep;69(3):138-43. doi: 10.1111/cod.12067.";Lindberg M;Contact Dermatitis;2013;17/08/2013;NA;NA;10.1111/cod.12067
210;17530670;Using Rasch analysis to compare the psychometric properties of the Short Form 36 physical function score and the Health Assessment Questionnaire disability index in patients with psoriatic arthritis and rheumatoid arthritis;Taylor WJ, McPherson KM.;"Arthritis Rheum. 2007 Jun 15;57(5):723-9. doi: 10.1002/art.22770.";Taylor WJ;Arthritis Rheum;2007;29/05/2007;NA;NA;10.1002/art.22770
211;31049926;Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study;Molloy K, Jonak C, Woei-A-Jin FJSH, Guenova E, Busschots AM, Bervoets A, Hauben E, Knobler R, Porkert S, Fassnacht C, Cowan R, Papadavid E, Beylot-Barry M, Berti E, Alberti Violetti S, Estrach T, Matin R, Akilov O, Vakeva L, Prince M, Bates A, Bayne M, Wachsmuch R, Wehkamp U, Marschalko M, Servitje O, Turner D, Weatherhead S, Wobser M, Sanches JA, McKay P, Klemke D, Peng C, Howles A, Yoo J, Evison F, Scarisbrick J.;"Br J Dermatol. 2020 Mar;182(3):770-779. doi: 10.1111/bjd.18089. Epub 2019 Jul 28.";Molloy K;Br J Dermatol;2020;04/05/2019;NA;NA;10.1111/bjd.18089
212;29873312;Proposed global drooping and wrinkles classification and scoring system for aging face with validation and experience on 54 Indian subjects;Garg S, Khan N, Makadia S.;"Indian J Dermatol Venereol Leprol. 2018 Nov-Dec;84(6):672-677. doi: 10.4103/ijdvl.IJDVL_418_17.";Garg S;Indian J Dermatol Venereol Leprol;2018;07/06/2018;NA;NA;10.4103/ijdvl.IJDVL_418_17
213;22919989;A comparative study in efficacy and safety of 0.1% tacrolimus and 0.05% clobetasol propionate ointment in discoid lupus erythematosus by modified cutaneous lupus erythematosus disease area and severity index;Pothinamthong P, Janjumratsang P.;"J Med Assoc Thai. 2012 Jul;95(7):933-40.";Pothinamthong P;J Med Assoc Thai;2012;28/08/2012;NA;NA;NA
214;30400871;"Exploratory study of the reproducibility of the SCore for INtrinsic and EXtrinsic skin aging (SCINEXA) scale in ""Ruta Escondida de la Mitad del Mundo"", Ecuador, 2017";Fors M, Palacios S, Falcon K, Ventimilla K, Simbaña L, Lagos C, Lasso N, Navas C.;"BMC Dermatol. 2018 Nov 6;18(1):10. doi: 10.1186/s12895-018-0078-9.";Fors M;BMC Dermatol;2018;08/11/2018;PMC6219042;NA;10.1186/s12895-018-0078-9
215;31215666;Comparison of five clinical scores for assessment of chronic hand eczema;Wang X, Xu W, Chen Y, Zhang C, Chen L, Lu Y, Li L, Shi W.;"J Dermatol. 2019 Nov;46(11):e433-e434. doi: 10.1111/1346-8138.14988. Epub 2019 Jun 19.";Wang X;J Dermatol;2019;20/06/2019;NA;NA;10.1111/1346-8138.14988
216;30564828;Assessment of modified Rodnan skin score and esophageal manometry in systemic sclerosis: a study correlating severity of skin and esophageal involvement by objective measures;Arif T, Adil M, Singh Sodhi J, Hassan I.;"Acta Dermatovenerol Alp Pannonica Adriat. 2018 Dec;27(4):169-173.";Arif T;Acta Dermatovenerol Alp Pannonica Adriat;2018;20/12/2018;NA;NA;NA
217;21769489;The correlation between durometer score and modified Rodnan skin score in systemic sclerosis;Moon KW, Song R, Kim JH, Lee EY, Lee EB, Song YW.;"Rheumatol Int. 2012 Aug;32(8):2465-70. doi: 10.1007/s00296-011-1993-9. Epub 2011 Jul 19.";Moon KW;Rheumatol Int;2012;20/07/2011;NA;NA;10.1007/s00296-011-1993-9
218;23869731;A simple tool with which to study the course of chronic hand eczema in clinical practice: a reduced-item score;van der Valk PG, van Gils RF, Boot CR, Evers AW, Donders R, Alkemade HA, Coenraads PJ, Rustemeyer T, van Mechelen W, Anema JR.;"Contact Dermatitis. 2013 Aug;69(2):112-7. doi: 10.1111/cod.12041.";van der Valk PG;Contact Dermatitis;2013;23/07/2013;NA;NA;10.1111/cod.12041
219;29368043;Comparison of Urticaria Activity Score Over 7 Days (UAS7) Values Obtained from Once-Daily and Twice-Daily Versions: Results from the ASSURE-CSU Study;Hollis K, Proctor C, McBride D, Balp MM, McLeod L, Hunter S, Tian H, Khalil S, Maurer M.;"Am J Clin Dermatol. 2018 Apr;19(2):267-274. doi: 10.1007/s40257-017-0331-8.";Hollis K;Am J Clin Dermatol;2018;26/01/2018;PMC5978890;NA;10.1007/s40257-017-0331-8
220;28328088;Evaluation of the correlation between severity of acquired idiopathic generalized anhidrosis and quality of life scores;Munetsugu T, Fujimoto T, Satoh T, Nakazato Y, Ohshima Y, Asahina M, Yokozeki H.;"J Dermatol. 2017 Jul;44(7):747-752. doi: 10.1111/1346-8138.13785. Epub 2017 Mar 22.";Munetsugu T;J Dermatol;2017;23/03/2017;NA;NA;10.1111/1346-8138.13785
221;33092467;Improving sensitivity of the connective tissue disease screening questionnaire: A comparative study of various scoring methods;Xiang L, Low AHL, Leung YY, Fong W, Gandhi M, Xin X, Uy EJ, Sparks JA, Karlson EW, Thumboo J.;"Lupus. 2021 Jan;30(1):35-44. doi: 10.1177/0961203320966378. Epub 2020 Oct 22.";Xiang L;Lupus;2021;23/10/2020;NA;NA;10.1177/0961203320966378
222;17519428;Scottish foot ulcer risk score predicts foot ulcer healing in a regional specialist foot clinic;Leese G, Schofield C, McMurray B, Libby G, Golden J, MacAlpine R, Cunningham S, Morris A, Flett M, Griffiths G.;"Diabetes Care. 2007 Aug;30(8):2064-9. doi: 10.2337/dc07-0553. Epub 2007 May 22.";Leese G;Diabetes Care;2007;24/05/2007;NA;NA;10.2337/dc07-0553
223;24716586;Application of the Itch Severity Score in patients with moderate-to-severe plaque psoriasis: Clinically important difference and responder analyses;Mamolo CM, Bushmakin AG, Cappelleri JC.;"J Dermatolog Treat. 2015 Apr;26(2):121-3. doi: 10.3109/09546634.2014.906033. Epub 2014 Apr 10.";Mamolo CM;J Dermatolog Treat;2015;11/04/2014;NA;NA;10.3109/09546634.2014.906033
224;18279297;Norton, Waterlow and Braden scores: a review of the literature and a comparison between the scores and clinical judgement;Anthony D, Parboteeah S, Saleh M, Papanikolaou P.;"J Clin Nurs. 2008 Mar;17(5):646-53. doi: 10.1111/j.1365-2702.2007.02029.x.";Anthony D;J Clin Nurs;2008;19/02/2008;NA;NA;10.1111/j.1365-2702.2007.02029.x
225;24406539;W.A.R. scores in patients with chronic leg ulcers: results of a multicentre study;Jockenhöfer F, Gollnick H, Herberger K, Isbary G, Renner R, Stücker M, Valesky E, Wollina U, Weichenthal M, Karrer S, Stoffels-Weindorf M, Dissemond J.;"J Wound Care. 2014 Jan;23(1):5-6, 8, 10-2. doi: 10.12968/jowc.2014.23.1.5.";Jockenhöfer F;J Wound Care;2014;11/01/2014;NA;NA;10.12968/jowc.2014.23.1.5
226;9737612;A regional pedal ischemia scoring system for decision analysis in patients with heel ulceration;Gentile AT, Berman SS, Reinke KR, Demas CP, Ihnat DH, Hughes JD, Mills JL.;"Am J Surg. 1998 Aug;176(2):109-14. doi: 10.1016/s0002-9610(98)00168-8.";Gentile AT;Am J Surg;1998;16/09/1998;NA;NA;10.1016/s0002-9610(98)00168-8
227;31781652;Angioedema Activity Score (AAS): A Valid and Reliable Tool to Use in Asian Patients;Kulthanan K, Chularojanamontri L, Rujitharanawong C, Weerasubpong P, Weller K, Maurer M.;"Biomed Res Int. 2019 Oct 31;2019:9157895. doi: 10.1155/2019/9157895. eCollection 2019.";Kulthanan K;Biomed Res Int;2019;30/11/2019;PMC6874972;NA;10.1155/2019/9157895
228;1451459;Monitoring of skin response to sodium lauryl sulphate: clinical scores versus bioengineering methods;van Neste D, de Brouwer B.;"Contact Dermatitis. 1992 Sep;27(3):151-6. doi: 10.1111/j.1600-0536.1992.tb05244.x.";van Neste D;Contact Dermatitis;1992;01/09/1992;NA;NA;10.1111/j.1600-0536.1992.tb05244.x
229;2778114;Do topical corticosteroids modulate skin irritation in human beings? Assessment by transepidermal water loss and visual scoring;van der Valk PG, Maibach HI.;"J Am Acad Dermatol. 1989 Sep;21(3 Pt 1):519-22. doi: 10.1016/s0190-9622(89)70219-x.";van der Valk PG;J Am Acad Dermatol;1989;01/09/1989;NA;NA;10.1016/s0190-9622(89)70219-x
230;31141154;Four-week Urticaria Activity Score-7 as a Useful Patient-reported Outcome to Assess Chronic Spontaneous Urticaria: A Multicentre Study Evaluation of Adherence and Patients' Perspective;Patruno C, Napolitano M, Ferrucci S, Brambilla L, Hansel K, Corazza M, Schena D, Foti C, Romita P, Gallo R, Stingeni L.;"Acta Derm Venereol. 2019 Sep 1;99(10):903-904. doi: 10.2340/00015555-3231.";Patruno C;Acta Derm Venereol;2019;30/05/2019;NA;NA;10.2340/00015555-3231
231;22192960;Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria;Mathias SD, Crosby RD, Zazzali JL, Maurer M, Saini SS.;"Ann Allergy Asthma Immunol. 2012 Jan;108(1):20-24. doi: 10.1016/j.anai.2011.09.008. Epub 2011 Nov 2.";Mathias SD;Ann Allergy Asthma Immunol;2012;24/12/2011;NA;NA;10.1016/j.anai.2011.09.008
232;20032989;Health-related quality of life assessment in dermatology: interpretation of Skindex-29 scores using patient-based anchors;Prinsen CA, Lindeboom R, Sprangers MA, Legierse CM, de Korte J.;"J Invest Dermatol. 2010 May;130(5):1318-22. doi: 10.1038/jid.2009.404. Epub 2009 Dec 24.";Prinsen CA;J Invest Dermatol;2010;25/12/2009;NA;NA;10.1038/jid.2009.404
233;30227189;Assessment of clinician accuracy for diagnosing melanoma on the basis of electrical impedance spectroscopy score plus morphology versus lesion morphology alone;Svoboda RM, Prado G, Mirsky RS, Rigel DS.;"J Am Acad Dermatol. 2019 Jan;80(1):285-287. doi: 10.1016/j.jaad.2018.08.048. Epub 2018 Sep 15.";Svoboda RM;J Am Acad Dermatol;2019;19/09/2018;NA;NA;10.1016/j.jaad.2018.08.048
234;20191495;A modified Sharp score demonstrates disease progression in established psoriatic arthritis;Ravindran J, Cavill C, Balakrishnan C, Jones SM, Korendowych E, McHugh NJ.;"Arthritis Care Res (Hoboken). 2010 Jan 15;62(1):86-91. doi: 10.1002/acr.20018.";Ravindran J;Arthritis Care Res (Hoboken);2010;02/03/2010;NA;NA;10.1002/acr.20018
235;34611063;Correlation between Interstitial Lung Disease Morphology Scores Based on High-resolution Computed Tomography Chest and Skin Fibrosis Degree Based on Modified Rodnan's Skin Score on Systemic Sclerosis;Hikmat IH, Ramdhini SS, Soekersi H, Dewi S.;"Acta Med Indones. 2021 Jul;53(3):254-260.";Hikmat IH;Acta Med Indones;2021;06/10/2021;NA;NA;NA
236;20000874;Topical treatment of actinic keratoses with piroxicam 1% gel: a preliminary open-label study utilizing a new clinical score;Campione E, Diluvio L, Paternò EJ, Chimenti S.;"Am J Clin Dermatol. 2010;11(1):45-50. doi: 10.2165/11311170-000000000-00000.";Campione E;Am J Clin Dermatol;2010;17/12/2009;NA;NA;10.2165/11311170-000000000-00000
237;29729201;Prurigo Activity Score (PAS): validity and reliability of a new instrument to monitor chronic prurigo;Pölking J, Zeidler C, Schedel F, Osada N, Augustin M, Metze D, Pereira MP, Yosipovitch G, Bernhard JD, Ständer S.;"J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1754-1760. doi: 10.1111/jdv.15040. Epub 2018 Jun 7.";Pölking J;J Eur Acad Dermatol Venereol;2018;06/05/2018;NA;NA;10.1111/jdv.15040
238;18047612;Marginal traction alopecia severity score: development and test of reliability;Khumalo NP, Ngwanya RM, Jessop S, Gumedze F, Ehrlich R.;"J Cosmet Dermatol. 2007 Dec;6(4):262-9. doi: 10.1111/j.1473-2165.2007.00345.x.";Khumalo NP;J Cosmet Dermatol;2007;01/12/2007;NA;NA;10.1111/j.1473-2165.2007.00345.x
239;14731251;Correlation between laser Doppler perfusion imaging and visual scoring of patch test sites in subjects with experimentally induced allergic and irritant contact reactions;Goon AT, Leow YH, Chan YH, Goh CL.;"Skin Res Technol. 2004 Feb;10(1):64-6. doi: 10.1111/j.1600-0846.2004.00060.x.";Goon AT;Skin Res Technol;2004;21/01/2004;NA;NA;10.1111/j.1600-0846.2004.00060.x
240;26881696;Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis;"Campanilho-Marques R, Almeida B, Deakin C, Arnold K, Gallot N, de Iorio M, Nistala K, Pilkington CA, Wedderburn LR; Juvenile Dermatomyositis Research Group.";"Arthritis Care Res (Hoboken). 2016 Oct;68(10):1514-21. doi: 10.1002/acr.22867. Epub 2016 Sep 16.";Campanilho-Marques R;Arthritis Care Res (Hoboken);2016;17/02/2016;PMC5053292;NA;10.1002/acr.22867
241;29128337;The Urticaria Activity Score-Validity, Reliability, and Responsiveness;Hawro T, Ohanyan T, Schoepke N, Metz M, Peveling-Oberhag A, Staubach P, Maurer M, Weller K.;"J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1185-1190.e1. doi: 10.1016/j.jaip.2017.10.001. Epub 2017 Nov 8.";Hawro T;J Allergy Clin Immunol Pract;2018;13/11/2017;NA;NA;10.1016/j.jaip.2017.10.001
242;22504052;Measuring sun exposure habits and sun protection behaviour using a comprehensive scoring instrument--an illustration of a possible model based on Likert scale scorings and on estimation of readiness to increase sun protection;Falk M, Anderson CD.;"Cancer Epidemiol. 2012 Aug;36(4):e265-9. doi: 10.1016/j.canep.2012.03.004. Epub 2012 Apr 13.";Falk M;Cancer Epidemiol;2012;17/04/2012;NA;NA;10.1016/j.canep.2012.03.004
243;12902800;An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score;"Carr A, Law M; HIV Lipodystrophy Case Definition Study Group.";"J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):571-6. doi: 10.1097/00126334-200308150-00004.";Carr A;J Acquir Immune Defic Syndr;2003;07/08/2003;NA;NA;10.1097/00126334-200308150-00004
244;28012019;Birmingham epidermolysis severity score and vitamin D status are associated with low BMD in children with epidermolysis bullosa;Rodari G, Guez S, Manzoni F, Chalouhi KK, Profka E, Bergamaschi S, Salera S, Tadini G, Ulivieri FM, Spada A, Giavoli C, Esposito S.;"Osteoporos Int. 2017 Apr;28(4):1385-1392. doi: 10.1007/s00198-016-3883-1. Epub 2016 Dec 23.";Rodari G;Osteoporos Int;2017;25/12/2016;NA;NA;10.1007/s00198-016-3883-1
245;30085349;What do Vitiligo Impact Scale-22 scores mean? Studying the clinical interpretation of scores using an anchor-based approach;Gupta V, Sreenivas V, Mehta M, Ramam M.;"Br J Dermatol. 2019 Mar;180(3):580-585. doi: 10.1111/bjd.17040. Epub 2018 Sep 26.";Gupta V;Br J Dermatol;2019;08/08/2018;NA;NA;10.1111/bjd.17040
246;21924716;Reanalyzing the modified Ferriman-Gallwey score: is there a simpler method for assessing the extent of hirsutism?;Cook H, Brennan K, Azziz R.;"Fertil Steril. 2011 Nov;96(5):1266-70.e1. doi: 10.1016/j.fertnstert.2011.08.022. Epub 2011 Sep 15.";Cook H;Fertil Steril;2011;20/09/2011;PMC3205229;NIHMS319134;10.1016/j.fertnstert.2011.08.022
247;29573393;Automated scoring of vitiligo using superpixel-generated computerized digital image analysis of clinical photographs: a novel and consistent way to score vitiligo;Toh JJH, Bhoi S, Tan VWD, Chuah SY, Jhingan A, Kong AWK, Thng STG.;"Br J Dermatol. 2018 Jul;179(1):220-221. doi: 10.1111/bjd.16563. Epub 2018 May 10.";Toh JJH;Br J Dermatol;2018;25/03/2018;NA;NA;10.1111/bjd.16563
248;28494438;Assessment of Intra- and Inter-Rater Reliability of Three Methods for Measuring Atopic Dermatitis Severity: EASI, Objective SCORAD, and IGA;Bozek A, Reich A.;"Dermatology. 2017;233(1):16-22. doi: 10.1159/000472711. Epub 2017 May 12.";Bozek A;Dermatology;2017;12/05/2017;NA;NA;10.1159/000472711
249;24809878;Analysis of body regions and components of PASI scores during adalimumab or methotrexate treatment for patients with moderate-to-severe psoriasis;Navarini AA, Poulin Y, Menter A, Gu Y, Teixeira HD.;"J Drugs Dermatol. 2014 May;13(5):554-62.";Navarini AA;J Drugs Dermatol;2014;10/05/2014;NA;NA;NA
250;16409095;Correlation between clinical scoring of allergic patch test reactions and optical coherence tomography;Gambichler T, Moussa G, Sand M, Sand D, Orlikov A, Altmeyer P, Hoffmann K.;"J Biomed Opt. 2005 Nov-Dec;10(6):064030. doi: 10.1117/1.2141933.";Gambichler T;J Biomed Opt;2005;18/01/2006;NA;NA;10.1117/1.2141933
251;19055204;The Atopic Dermatitis Quickscore (ADQ): validation of a new parent-administered atopic dermatitis scoring tool;Carel K, Bratton DL, Miyazawa N, Gyorkos E, Kelsay K, Bender B, Strand M, Atkins D, Gelfand EW, Klinnert MD.;"Ann Allergy Asthma Immunol. 2008 Nov;101(5):500-7. doi: 10.1016/S1081-1206(10)60289-X.";Carel K;Ann Allergy Asthma Immunol;2008;06/12/2008;NA;NA;10.1016/S1081-1206(10)60289-X
252;33598997;Increasing competence in compression therapy for venous leg ulcers through training and exercise measured by a newly developed score-Results of a randomised controlled intervention study;Protz K, Dissemond J, Karbe D, Augustin M, Klein TM.;"Wound Repair Regen. 2021 Mar;29(2):261-269. doi: 10.1111/wrr.12899. Epub 2021 Feb 18.";Protz K;Wound Repair Regen;2021;18/02/2021;NA;NA;10.1111/wrr.12899
253;25196258;Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life;Coutanceau C, Stalder JF.;"Dermatology. 2014;229(3):248-55. doi: 10.1159/000365075. Epub 2014 Aug 29.";Coutanceau C;Dermatology;2014;09/09/2014;NA;NA;10.1159/000365075
254;28429820;Clinical bandings of Patient-Oriented Eczema Measure scores among Japanese patients with atopic eczema;Yasukochi Y, Kido-Nakahara M, Nakahara T, Kuroki R, Koga T, Mashino T, Kurihara Y, Furue M.;"Br J Dermatol. 2017 Nov;177(5):e211-e212. doi: 10.1111/bjd.15599. Epub 2017 Oct 25.";Yasukochi Y;Br J Dermatol;2017;22/04/2017;NA;NA;10.1111/bjd.15599
255;12410700;Comparison of different activity parameters in atopic dermatitis: correlation with clinical scores;Gutgesell C, Heise S, Seubert A, Stichtenoth DO, Frölich JC, Neumann C.;"Br J Dermatol. 2002 Nov;147(5):914-9. doi: 10.1046/j.1365-2133.2002.04938.x.";Gutgesell C;Br J Dermatol;2002;02/11/2002;NA;NA;10.1046/j.1365-2133.2002.04938.x
256;25229692;Results of the validation study of the Psodisk instrument, and determination of the cut-off scores for varying degrees of impairment;Sampogna F, Linder D, Romano GV, Gualberti G, Merolla R, di Luzio Paparatti U.;"J Eur Acad Dermatol Venereol. 2015 Apr;29(4):725-31. doi: 10.1111/jdv.12668. Epub 2014 Sep 17.";Sampogna F;J Eur Acad Dermatol Venereol;2015;18/09/2014;NA;NA;10.1111/jdv.12668
257;21055711;Usefulness of the framingham risk score in patients with chronic psoriasis;Gisondi P, Farina S, Giordano MV, Girolomoni G.;"Am J Cardiol. 2010 Dec 15;106(12):1754-7. doi: 10.1016/j.amjcard.2010.08.016. Epub 2010 Nov 4.";Gisondi P;Am J Cardiol;2010;09/11/2010;NA;NA;10.1016/j.amjcard.2010.08.016
258;18480921;Itch intensity evaluated in the German Atopic Dermatitis Intervention Study (GADIS): correlations with quality of life, coping behaviour and SCORAD severity in 823 children;Weisshaar E, Diepgen TL, Bruckner T, Fartasch M, Kupfer J, Lob-Corzilius T, Ring J, Scheewe S, Scheidt R, Schmid-Ott G, Schnopp C, Staab D, Szcepanski R, Werfel T, Wittenmeier M, Wahn U, Gieler U.;"Acta Derm Venereol. 2008;88(3):234-9. doi: 10.2340/00015555-0432.";Weisshaar E;Acta Derm Venereol;2008;16/05/2008;NA;NA;10.2340/00015555-0432
259;19644851;Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials;"Amjadi S, Maranian P, Furst DE, Clements PJ, Wong WK, Postlethwaite AE, Khanna PP, Khanna D; Investigators of the D-Penicillamine, Human Recombinant Relaxin, and Oral Bovine Type I Collagen Clinical Trials.";"Arthritis Rheum. 2009 Aug;60(8):2490-8. doi: 10.1002/art.24681.";Amjadi S;Arthritis Rheum;2009;01/08/2009;PMC2725229;NIHMS117401;10.1002/art.24681
260;31705538;The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials;Kirby JS, Thorlacius L, Villumsen B, Ingram JR, Garg A, Christensen KB, Butt M, Esmann S, Tan J, Jemec GBE.;"Br J Dermatol. 2020 Aug;183(2):340-348. doi: 10.1111/bjd.18692. Epub 2019 Dec 26.";Kirby JS;Br J Dermatol;2020;10/11/2019;PMC7205560;NIHMS1058982;10.1111/bjd.18692
261;31203221;Treating Psoriatic Arthritis to Target: Defining the Psoriatic Arthritis Disease Activity Score That Reflects a State of Minimal Disease Activity;Perruccio AV, Got M, Li S, Ye Y, Gladman DD, Chandran V.;"J Rheumatol. 2020 Mar;47(3):362-368. doi: 10.3899/jrheum.181472. Epub 2019 Jun 15.";Perruccio AV;J Rheumatol;2020;17/06/2019;NA;NA;10.3899/jrheum.181472
262;22555198;Validation of the Self-Assessment of Melanoma Risk Score for a melanoma-targeted screening;Quéreux G, N'guyen JM, Cary M, Jumbou O, Lequeux Y, Dréno B.;"Eur J Cancer Prev. 2012 Nov;21(6):588-95. doi: 10.1097/CEJ.0b013e328353ed68.";Quéreux G;Eur J Cancer Prev;2012;05/05/2012;NA;NA;10.1097/CEJ.0b013e328353ed68
263;32603719;Clinically meaningful change in itch intensity scores: An evaluation in patients with chronic kidney disease-associated pruritus;Vernon M, Ständer S, Munera C, Spencer RH, Menzaghi F.;"J Am Acad Dermatol. 2021 Apr;84(4):1132-1134. doi: 10.1016/j.jaad.2020.06.991. Epub 2020 Jun 27.";Vernon M;J Am Acad Dermatol;2021;01/07/2020;NA;NA;10.1016/j.jaad.2020.06.991
264;16361712;There is no correlation between acne severity and AQOLS/DLQI scores;Ilgen E, Derya A.;"J Dermatol. 2005 Sep;32(9):705-10. doi: 10.1111/j.1346-8138.2005.tb00829.x.";Ilgen E;J Dermatol;2005;20/12/2005;NA;NA;10.1111/j.1346-8138.2005.tb00829.x
265;21317856;A global approach to psoriatic patients through PASI score and Skindex-29;Prignano F, Ruffo G, Ricceri F, Pescitelli L, Lotti T.;"G Ital Dermatol Venereol. 2011 Feb;146(1):47-52.";Prignano F;G Ital Dermatol Venereol;2011;15/02/2011;NA;NA;NA
266;21399503;Development of an individual score for melanoma risk;Quéreux G, Moyse D, Lequeux Y, Jumbou O, Brocard A, Antonioli D, Dréno B, Nguyen JM.;"Eur J Cancer Prev. 2011 May;20(3):217-24. doi: 10.1097/CEJ.0b013e32834474ae.";Quéreux G;Eur J Cancer Prev;2011;15/03/2011;NA;NA;10.1097/CEJ.0b013e32834474ae
267;11532378;Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis;Sato S, Hasegawa M, Takehara K.;"J Dermatol Sci. 2001 Oct;27(2):140-6. doi: 10.1016/s0923-1811(01)00128-1.";Sato S;J Dermatol Sci;2001;05/09/2001;NA;NA;10.1016/s0923-1811(01)00128-1
268;2083081;Objective assessment of topical anti-inflammatory drug activity on experimentally induced nickel contact dermatitis: comparison between visual scoring, colorimetry, laser Doppler velocimetry and transepidermal water loss;Queille-Roussel C, Duteil L, Padilla JM, Poncet M, Czernielewski J.;"Skin Pharmacol. 1990;3(4):248-55. doi: 10.1159/000210877.";Queille-Roussel C;Skin Pharmacol;1990;01/01/1990;NA;NA;10.1159/000210877
269;18311761;Alternative scoring of the Cutaneous Assessment Tool in juvenile dermatomyositis: results using abbreviated formats;"Huber AM, Lachenbruch PA, Dugan EM, Miller FW, Rider LG; Juvenile Dermatomyositis Disease Activity Collaborative Study Group.";"Arthritis Rheum. 2008 Mar 15;59(3):352-6. doi: 10.1002/art.23313.";Huber AM;Arthritis Rheum;2008;04/03/2008;PMC2598766;NIHMS45079;10.1002/art.23313
270;17433002;Atopic dermatitis: quality of life of young Italian children and their families and correlation with severity score;Ricci G, Bendandi B, Bellini F, Patrizi A, Masi M.;"Pediatr Allergy Immunol. 2007 May;18(3):245-9. doi: 10.1111/j.1399-3038.2006.00502.x.";Ricci G;Pediatr Allergy Immunol;2007;17/04/2007;NA;NA;10.1111/j.1399-3038.2006.00502.x
271;16428150;Effectiveness of climatotherapy at the Dead Sea for psoriasis vulgaris: A community-oriented study introducing the 'Beer Sheva Psoriasis Severity Score';Cohen AD, Van-Dijk D, Naggan L, Vardy DA.;"J Dermatolog Treat. 2005;16(5-6):308-13. doi: 10.1080/09546630500375841.";Cohen AD;J Dermatolog Treat;2005;24/01/2006;NA;NA;10.1080/09546630500375841
272;30506714;Comparison of 2-D shear wave elastography with clinical score in localized scleroderma: A new method to increase the diagnostic accuracy;Wang Y, Shan JL, Chen HY, Wu ZF.;"J Dermatol. 2019 Feb;46(2):131-138. doi: 10.1111/1346-8138.14713. Epub 2018 Dec 3.";Wang Y;J Dermatol;2019;04/12/2018;NA;NA;10.1111/1346-8138.14713
273;12657392;A severity score for complicated skin and soft tissue infections derived from phase III studies of linezolid;Wilson SE, Solomkin JS, Le V, Cammarata SK, Bruss JB.;"Am J Surg. 2003 Apr;185(4):369-75. doi: 10.1016/s0002-9610(02)01411-3.";Wilson SE;Am J Surg;2003;27/03/2003;NA;NA;10.1016/s0002-9610(02)01411-3
274;32326955;A caregiver-reported global severity assessment in pediatric atopic eczema: the Comano score;Giovannini M, Geat D, Barlocco G, Pertile R, Mori F, Filippeschi C, Novembre E, Cristofolini M, Baldo E.;"Ital J Pediatr. 2020 Apr 23;46(1):50. doi: 10.1186/s13052-020-0805-9.";Giovannini M;Ital J Pediatr;2020;25/04/2020;PMC7181490;NA;10.1186/s13052-020-0805-9
275;19671126;The value of a wound score for diabetic foot infections in predicting treatment outcome: a prospective analysis from the SIDESTEP trial;Lipsky BA, Polis AB, Lantz KC, Norquist JM, Abramson MA.;"Wound Repair Regen. 2009 Sep-Oct;17(5):671-7. doi: 10.1111/j.1524-475X.2009.00521.x. Epub 2009 Aug 11.";Lipsky BA;Wound Repair Regen;2009;13/08/2009;NA;NA;10.1111/j.1524-475X.2009.00521.x
276;25713022;Development and validation of a melanoma risk score based on pooled data from 16 case-control studies;Davies JR, Chang YM, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, Green A, Gruis NA, Holly EA, Ingvar C, Kanetsky PA, Karagas MR, Lee TK, Le Marchand L, Mackie RM, Olsson H, Østerlind A, Rebbeck TR, Reich K, Sasieni P, Siskind V, Swerdlow AJ, Titus L, Zens MS, Ziegler A, Gallagher RP, Barrett JH, Newton-Bishop J.;"Cancer Epidemiol Biomarkers Prev. 2015 May;24(5):817-24. doi: 10.1158/1055-9965.EPI-14-1062. Epub 2015 Feb 24.";Davies JR;Cancer Epidemiol Biomarkers Prev;2015;26/02/2015;PMC4487528;NIHMS663274;10.1158/1055-9965.EPI-14-1062
277;21414011;Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe;"Stalder JF, Barbarot S, Wollenberg A, Holm EA, De Raeve L, Seidenari S, Oranje A, Deleuran M, Cambazard F, Svensson A, Simon D, Benfeldt E, Reunala T, Mazereeuv J, Boralevi F, Kunz B, Misery L, Mortz CG, Darsow U, Gelmetti C, Diepgen T, Ring J, Moehrenschlager M, Gieler U, Taïeb A; PO-SCORAD Investigators Group.";"Allergy. 2011 Aug;66(8):1114-21. doi: 10.1111/j.1398-9995.2011.02577.x. Epub 2011 Mar 18.";Stalder JF;Allergy;2011;19/03/2011;NA;NA;10.1111/j.1398-9995.2011.02577.x
278;15294022;DLQI scores in vitiligo: reliability and validity of the Persian version;Aghaei S, Sodaifi M, Jafari P, Mazharinia N, Finlay AY.;"BMC Dermatol. 2004 Aug 4;4:8. doi: 10.1186/1471-5945-4-8.";Aghaei S;BMC Dermatol;2004;06/08/2004;PMC514558;NA;10.1186/1471-5945-4-8
279;29914516;Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma;Agazzi A, Fadanelli G, Vittadello F, Zulian F, Martini G.;"Pediatr Rheumatol Online J. 2018 Jun 18;16(1):37. doi: 10.1186/s12969-018-0254-9.";Agazzi A;Pediatr Rheumatol Online J;2018;20/06/2018;PMC6006585;NA;10.1186/s12969-018-0254-9
280;12535287;Validation and clinical relevance of a novel scalp coverage scoring method;Van Neste D, Leroy T, Sandraps E.;"Skin Res Technol. 2003 Feb;9(1):64-72. doi: 10.1034/j.1600-0846.2003.00368.x.";Van Neste D;Skin Res Technol;2003;22/01/2003;NA;NA;10.1034/j.1600-0846.2003.00368.x
281;17531782;A single-center pilot validation study of a new chronic GVHD skin scoring system;Greinix HT, Pohlreich D, Maalouf J, Soukup P, Supper V, Kalhs P, Knobler RM.;"Biol Blood Marrow Transplant. 2007 Jun;13(6):715-23. doi: 10.1016/j.bbmt.2007.02.007. Epub 2007 Apr 23.";Greinix HT;Biol Blood Marrow Transplant;2007;29/05/2007;NA;NA;10.1016/j.bbmt.2007.02.007
282;20579644;Hirsutism scoring in polycystic ovary syndrome: concordance between clinicians' and patients' self-scoring;Espinós JJ, Calaf J, Estadella J, Checa MA.;"Fertil Steril. 2010 Dec;94(7):2815-6. doi: 10.1016/j.fertnstert.2010.05.022. Epub 2010 Jun 25.";Espinós JJ;Fertil Steril;2010;29/06/2010;NA;NA;10.1016/j.fertnstert.2010.05.022
283;1466184;A double-blind comparison of two creams containing urea as the active ingredient. Assessment of efficacy and side-effects by non-invasive techniques and a clinical scoring scheme;Serup J.;"Acta Derm Venereol Suppl (Stockh). 1992;177:34-43.";Serup J;Acta Derm Venereol Suppl (Stockh);1992;01/01/1992;NA;NA;NA
284;34491666;"Hindi translation and validation of quality of life score in Indian patients with epidermolysis bullosa; and its correlation with the clinical severity assessment scores: A cross-sectional study";Bishnoi A, Manjunath S, Kishore K, De D, Handa S, Murrell DF, Mahajan R.;"Indian J Dermatol Venereol Leprol. 2022 Mar-Apr;88(2):177-183. doi: 10.25259/IJDVL_31_20.";Bishnoi A;Indian J Dermatol Venereol Leprol;2022;07/09/2021;NA;NA;10.25259/IJDVL_31_20
285;21986157;Hirsutism score and the severity of hyperandrogenism associated with polycystic ovary syndrome in the southeastern region of Turkey;Demir B, Pasa S, Demir S, Tumer C, Atay AE, Gul T, Atamer Y.;"J Int Med Res. 2011;39(4):1529-35. doi: 10.1177/147323001103900443.";Demir B;J Int Med Res;2011;12/10/2011;NA;NA;10.1177/147323001103900443
286;17205494;The Ulcerated Leg Severity Assessment score for prediction of venous leg ulcer healing;Kulkarni SR, Gohel MS, Wakely C, Minor J, Poskitt KR, Whyman MR.;"Br J Surg. 2007 Feb;94(2):189-93. doi: 10.1002/bjs.5597.";Kulkarni SR;Br J Surg;2007;06/01/2007;NA;NA;10.1002/bjs.5597
287;25660989;Correlation between Objective SCORAD and Three-Item Severity Score used by physicians and Objective PO-SCORAD used by parents/patients in children with atopic dermatitis;van Oosterhout M, Janmohamed SR, Spierings M, Hiddinga J, de Waard-van der Spek FB, Oranje AP.;"Dermatology. 2015;230(2):105-12. doi: 10.1159/000367689. Epub 2015 Jan 31.";van Oosterhout M;Dermatology;2015;10/02/2015;NA;NA;10.1159/000367689
288;28625808;Relationship between EASI and SCORAD severity assessments for atopic dermatitis;Chopra R, Vakharia PP, Sacotte R, Patel N, Immaneni S, White T, Kantor R, Hsu DY, Silverberg JI.;"J Allergy Clin Immunol. 2017 Dec;140(6):1708-1710.e1. doi: 10.1016/j.jaci.2017.04.052. Epub 2017 Jun 15.";Chopra R;J Allergy Clin Immunol;2017;20/06/2017;PMC5723207;NIHMS885299;10.1016/j.jaci.2017.04.052
289;25887796;Patient-centered psoriatic arthritis (PsA) activity assessment by Stockerau Activity Score for Psoriatic Arthritis (SASPA);Leeb BF, Haindl PM, Brezinschek HP, Mai HT, Deutsch C, Rintelen B.;"BMC Musculoskelet Disord. 2015 Apr 1;16:73. doi: 10.1186/s12891-015-0512-7.";Leeb BF;BMC Musculoskelet Disord;2015;19/04/2015;PMC4393861;NA;10.1186/s12891-015-0512-7
290;22747950;Predictive validity of weekly monitoring of wound status using DESIGN-R score change for pressure ulcer healing: a multicenter prospective cohort study;"Iizaka S, Sanada H, Matsui Y, Furue M, Tachibana T, Nakayama T, Sugama J, Furuta K, Tachi M, Tokunaga K, Miyachi Y; Scientific Education Committee of the Japanese Society of Pressure Ulcers.";"Wound Repair Regen. 2012 Jul-Aug;20(4):473-81. doi: 10.1111/j.1524-475X.2012.00778.x.";Iizaka S;Wound Repair Regen;2012;04/07/2012;NA;NA;10.1111/j.1524-475X.2012.00778.x
291;24064003;Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease;"Varsani H, Charman SC, Li CK, Marie SK, Amato AA, Banwell B, Bove KE, Corse AM, Emslie-Smith AM, Jacques TS, Lundberg IE, Minetti C, Nennesmo I, Rushing EJ, Sallum AM, Sewry C, Pilkington CA, Holton JL, Wedderburn LR; UK Juvenile Dermatomyositis Research Group.";"Ann Rheum Dis. 2015 Jan;74(1):204-10. doi: 10.1136/annrheumdis-2013-203396. Epub 2013 Sep 24.";Varsani H;Ann Rheum Dis;2015;26/09/2013;PMC4283618;NA;10.1136/annrheumdis-2013-203396
292;9292072;Characterization of irritant patch test reactions to topical D vitamins and all-trans retinoic acid in comparison with sodium lauryl sulphate. Evaluation by clinical scoring and multiparametric non-invasive measuring techniques;Fullerton A, Serup J.;"Br J Dermatol. 1997 Aug;137(2):234-40. doi: 10.1046/j.1365-2133.1997.18111911.x.";Fullerton A;Br J Dermatol;1997;01/08/1997;NA;NA;10.1046/j.1365-2133.1997.18111911.x
293;10334682;A patient-derived disease activity score can substitute for a physician-derived disease activity score in clinical research;Houssien DA, Stucki G, Scott DL.;"Rheumatology (Oxford). 1999 Jan;38(1):48-52. doi: 10.1093/rheumatology/38.1.48.";Houssien DA;Rheumatology (Oxford);1999;20/05/1999;NA;NA;10.1093/rheumatology/38.1.48
294;10563710;Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations;Christeff N, Melchior JC, de Truchis P, Perronne C, Nunez EA, Gougeon ML.;"AIDS. 1999 Nov 12;13(16):2251-60. doi: 10.1097/00002030-199911120-00007.";Christeff N;AIDS;1999;24/11/1999;NA;NA;10.1097/00002030-199911120-00007
295;29511009;Factor structure and convergent validity of the Derriford Appearance Scale-24 using standard scoring versus treating 'not applicable' responses as missing data: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study;"Merz EL, Kwakkenbos L, Carrier ME, Gholizadeh S, Mills SD, Fox RS, Jewett LR, Williamson H, Harcourt D, Assassi S, Furst DE, Gottesman K, Mayes MD, Moss TP, Thombs BD, Malcarne VL; SPIN Investigators.";"BMJ Open. 2018 Mar 6;8(3):e018641. doi: 10.1136/bmjopen-2017-018641.";Merz EL;BMJ Open;2018;08/03/2018;PMC5855329;NA;10.1136/bmjopen-2017-018641
296;19843682;Associations between silicone skin cast score, cumulative sun exposure, and other factors in the ausimmune study: a multicenter Australian study;Lucas RM, Ponsonby AL, Dear K, Taylor BV, Dwyer T, McMichael AJ, Valery P, van der Mei I, Williams D, Pender MP, Chapman C, Coulthard A, Kilpatrick T.;"Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2887-94. doi: 10.1158/1055-9965.EPI-09-0191. Epub 2009 Oct 20.";Lucas RM;Cancer Epidemiol Biomarkers Prev;2009;22/10/2009;NA;NA;10.1158/1055-9965.EPI-09-0191
297;31511042;Relationship of mottling score, skin microcirculatory perfusion indices and biomarkers of endothelial dysfunction in patients with septic shock: an observational study;Kazune S, Caica A, Volceka K, Suba O, Rubins U, Grabovskis A.;"Crit Care. 2019 Sep 11;23(1):311. doi: 10.1186/s13054-019-2589-0.";Kazune S;Crit Care;2019;13/09/2019;PMC6739999;NA;10.1186/s13054-019-2589-0
298;9451264;Can primary prevention or selective screening for melanoma be more precisely targeted through general practice? A prospective study to validate a self administered risk score;Jackson A, Wilkinson C, Ranger M, Pill R, August P.;"BMJ. 1998 Jan 3;316(7124):34-8; discussion 38-9. doi: 10.1136/bmj.316.7124.34.";Jackson A;BMJ;1998;06/02/1998;PMC2665326;NA;10.1136/bmj.316.7124.34
